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Large-conductance voltage- and Ca2+-activated potassium (BK) channels are 
critical modulators of cellular excitability throughout the cardiovascular and nervous 
systems.  The first aim of this work focuses on a novel role for BK channels in 
regulating cardiac pacing.  Recently, BK channels were implicated in heart rate 
regulation, but the underlying mechanism was unclear.  We hypothesized that BK 
channels regulate heart rate by modulating the intrinsic excitability of sinoatrial node 
cells (SANCs), the predominant cardiac pacemaking cells.  We found that BK 
channel protein was expressed in SANCs, and that elimination of BK currents via 
pharmacological inhibition and genetic ablation reduces SANC excitability.  
Additionally, we characterized the properties of BK currents from SANCs.  Our 
results indicate that BK channels are novel regulators of SANC function, and suggest 




The second aim of this work focuses on the effect of single-nucleotide 
polymorphisms (SNPs) on BK current properties.  There are approximately 100 
known non-synonymous SNPs in human KCNMA1, the gene that encodes BK 
channels, but few have been characterized or linked with disease.  We hypothesized 
that SNPs in KCNMA1 associated with disease, or located in domains of the BK 
channel gating ring that mediate Ca2+-dependent activation would alter BK current 
properties.  We determined that the effects of SNPs on BK current properties were 
Ca2+ concentration-dependent.  Also, we found that SNP-induced alterations in 
current kinetics influenced the amplitude of BK currents evoked by action potential 
waveforms.  These results indicate that SNPs in KCNMA1 can modulate BK current 
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Chapter 1: Introduction  
 
 BK (KCa1.1, Maxi-K) channels are large-conductance Ca2+- and voltage activated 
potassium channels that are that are gated by membrane depolarization and elevation of 
intracellular Ca2+ (Marty, 1983).  BK channels are encoded by a single Kcnma1 (slo1) 
gene (Butler et al., 1993; Meredith et al., 2004), and the pore-forming subunit of the 
channel consists of a tetramer of α-subunits (Shen et al., 1994).  Each α-subunit is 
defined by seven transmembrane domains that regulate voltage sensing and form the 
channel pore, an extracellular NH2 (N) terminus, and an intracellular -COOH (C) 
terminus that forms the channel gating ring and regulates Ca2+ sensitivity (Meera et al., 
1997) (Figure 1).  BK currents are classified by their large single-channel conductance, 
outward currents in response to membrane depolarization and/or intracellular Ca2+, and 
sensitivity to specific toxins and inhibitors (Butler et al., 1993; Cui et al., 2009; Knaus et 
al., 1994; Latorre and Miller, 1983; Meera et al., 2000).  BK current properties can be 
modulated through a variety of mechanisms, including posttranslational modifications, 
auxiliary subunits, and alternative splicing (Brenner et al., 2000; Davies et al., 2003; Xie 
and McCobb, 1998; Yan et al., 2008). 
 Physiologically, BK channels are essential regulators of excitability throughout 
the cardiovascular and nervous systems.  In the cardiovascular system, BK channels are 
expressed throughout vascular smooth muscle, and opening of BK channels facilitates 
vasodilation (Nelson et al., 1995).  Also, multiple reports indicate that activation of 
mitochondrial BK channels protects the heart against ischemic injury (Bentzen et al., 
2009; Singh et al., 2013; Xu et al., 2002).  In neurons, BK channels can regulate the 




2002; Storm, 1987), as well as mediate neurotransmitter release (Raffaelli et al., 2004).  
Additionally, neuronal excitability can be mediated by changes in BK channel expression 
and current properties (Meredith et al., 2006; Shelley et al., 2013). 
 BK channels have profound clinical relevance due to their ubiquitous expression 
throughout the cardiovascular and nervous systems.  BK channel dysfunction can 
contribute to several conditions, including hypertension, diabetes, and epilepsy (Du et al., 
2005; England et al., 1993; McGahon et al., 2007; Wan et al., 2013).  Because of the vast 
number of physiological roles for BK channels, it would be extremely beneficial to have 
therapies designed to selectively target and modulate BK currents in order to potentially 
treat pathophysiological conditions.  Therefore, it is of utmost importance to continue to 
elucidate novel physiological roles for BK channels so that more effect treatments can be 
developed. 
1.1 BK channel structure 
 The BK channel pore-forming subunit consists of a tetramer of α-subunits, and 
each α-subunit contains seven transmembrane domains (S0–S6) and an intracellular 
COOH-terminus (Meera et al., 1997) (Figure 1).  The S1-S4 domains form the voltage-
sensing domain (VSD), which regulates voltage-dependent gating of the channels, while 
the S5-S6 domains form the channel pore (Meera et al., 1997).  Although the BK channel 
VSD and pore are similar in structure to other voltage-gated K+ channels (Atkinson et al., 
1991; Butler et al., 1993), BK channels contain a seventh transmembrane domain (S0) at 
the NH2-terminal end (Meera et al., 1997; Wallner et al., 1996).  The S0 domain 
modulates voltage-dependent gating (Koval et al., 2007), and is essential for α-subunit 




transmembrane domain proteins that regulate multiple current properties, including Ca2+ 
sensitivity and activation kinetics (Brenner et al., 2000a; McCobb et al., 1995). 
 The VSD consists of the S1-S4 transmembrane domains (Figure 1).  The S4 
domain is the primary voltage sensor, and it contains three positively charged arginine 
residues (R207, R210, R213) that are conserved across other K+ channels and regulate 
the voltage-dependent activation (Cui and Aldrich, 2000; Díaz et al., 1998; Ma et al., 
2006).  In addition to the charged residues in S4, several other charged residues in S2 and 
S3 have been implicated in voltage-sensing, including D153, R167, and D186.  TM 
domains S5 and S6 form the central pore and pore helix of the channel.  The pore 
structure is similar to that of other K+ channels, as it contains a K+ selectivity filter 
(Brelidze et al., 2003; Heginbotham et al., 1994), as well as an external turret between 
S5-S6 that mediates toxin selectivity (Giangiacomo et al., 2008).  Additionally, the pore 
contains a ring of eight glutamic acid residues (E321 and E324), which reside below the 
selectivity filter and enable the channel’s large single-channel conductance (Brelidze et 
al., 2003).   
 The C-terminus of each BK channel α-subunit contains four additional 
hydrophobic segments (S7-S10)(Meera et al., 1997) that form the channel gating ring 
(Wu et al., 2010; Yuan et al., 2010; 2011) (Figure 1).  Each C-terminus contains two 
“regulators of K+ conductance” (RCK) domains (Wu et al., 2010; Yuan et al., 2011), and 
within these RCK domains are two high-affinity Ca2+ sensing sites (Schreiber and 
Salkoff, 1997; Xia et al., 2002; Zhang et al., 2010).  The first residues identified to 
regulate Ca2+ sensing were within the “Ca2+-bowl,” a group of five consecutive aspartic 




the negatively charged aspartic acids were neutralized through mutation to asparagine 
(5D5N), causing a 60-70 mV rightward shift in the conductance-voltage (G-V) curve 
compared to wild-type (WT) channels at low (4 µM Ca2+) and saturating (1 mM) Ca2+ 
concentrations (Schreiber and Salkoff, 1997; Xia et al., 2002).  Additionally, crystal 
structures of the BK channel gating ring suggest that Ca2+ binds directly within Ca2+ bowl 
and causes a conformational change that promotes opening of the pore (Yuan et al., 
2011). 
 The mouse D362, D367 and E535 residues are the critical residues in the BK 
RCK1 domain that form the second high-affinity Ca2+ sensing site.  Through alignment 
of the BK channel (slo1) sequence with slo3, a BK channel homologue that is regulated 
by pH rather than Ca2+, it was determined that D362 and D367 were not conserved, 
suggesting that D362 and D367 may regulate Ca2+ sensing (Xia et al., 2002).  It was then 
discovered that mutating D362/D367 to alanine caused a +100 mV positive shift in the 
G-V relationship compared to WT channels in saturating Ca2+ conditions.  This indicated 
that D362/D367 were essential for Ca2+ sensitivity (Xia et al., 2002).  Later, it was 
demonstrated that E535 was also an essential residue to the RCK1 Ca2+ sensitivity site, as 
E535A shifted the G-V relationship towards positive potentials in a similar manner 
compared to the D362A/D367A mutations (Zhang et al., 2010).   














Figure 1: BK channel structure and currents 
(A) Topology of a BK channel α-subunit.  Each α-subunit has an extracellular N- 
terminus, voltage-sensing domain (VSD, S1-S4), pore (S5-S6), and an intracellular C-
terminus.  The C-terminus, which contains two RCK domains, forms the channel gating 
ring.  Each RCK domain contains a high-affinity Ca2+ coordination site.  (B) BK currents 
are activated by membrane depolarization and Ca2+.  BK currents were evoked using 
depolarizing voltage steps from BK channels in an inside-out patch configuration in 
symmetrical K+ at the indicated concentration of Ca2+.  (C) Normalized conductance-
voltage (G-V) relationship for BK currents at indicated Ca2+.  Current activation becomes 
more robust and the G-V relationship is shifted toward more negative potentials as 






1.2 Allosteric regulation of BK currents by Ca2+ and voltage 
 BK channels can open through solely Ca2+- or voltage-dependent mechanisms; in 
zero-Ca2+ conditions, the single-channel open probability (PO) increases with membrane 
depolarization due to voltage-sensor activation (Figure 2A, Figure 2C) (Meera et al., 
1996; Rothberg and Magleby, 2000; Talukder and Aldrich, 2000).  Alternatively, the PO 
can be increased, even at hyperpolarized potentials where the voltage-sensor is not 
intrinsically activated, by elevation of intracellular Ca2+ (Figure 2B)(Rothberg and 
Magleby, 2000).  Although these pathways can open the channel pore independently, the 
pathways are also uniquely allosterically coupled, as demonstrated by the Horrigan-
Aldrich model (Horrigan and Aldrich, 2002) (Figure 3).  In this model, PO is described as 
a function of voltage-sensor activation and Ca2+ binding.  A key aspect of the model is 
that changes in membrane potential or intracellular Ca2+ that affect the state of the 
voltage sensors or Ca2+ binding, respectively, will directly affect each other and will 
consequently affect PO.  Therefore, it is essential to identify residues that affect voltage- 









Figure 2: BK currents can be activated independently through either Ca2+ or 
voltage-dependent pathways 
Single channel openings were recorded from BK channels in an inside-out patch 
configuration at the indicated Ca2+ concentrations and voltages.  (A) BK channels have a 
low open probability (PO) and are closed, as denoted by “C,” in conditions where there is 
no Ca2+ and the membrane is hyperpolarized.  Channels can open solely through  Ca2+-
dependent (B) or voltage-dependent mechanisms (C).  Because BK channels are 
allosterically activated, voltage- and Ca2+-dependent activation are coupled.  The number 
of channels opening at one time in (B) and (C) are denoted by “O”.  Single channel 















Figure 3: Horrigan-Aldrich model of allosteric activation of BK channels  
Each BK channel subunit can be activated by voltage and Ca2+ (Horrigan and Aldrich, 
2002).  Because BK channels consist of a tetramer of α-subunits, the model incorporates 
four voltage sensors (blue brackets, left) and at least four high-affinity Ca2+ binding sites 
(black brackets, right).  Each of the voltage sensors can transition between resting (R) and 
active (A) states, which is governed by an equilibrium factor J.  Each Ca2+ binding site 
can transition between a Ca2+-unbound (X) and Ca2+-bound (XCa) state, which is 
governed by an equilibrium constant K.  The channel pore can be either in the closed (C) 
or the open (O) state, which is governed by the equilibrium constant L.  In Ca2+-free 
conditions, the interaction between the voltage sensors and the channel pore is regulated 
by an allosteric factor D.  In conditions where the voltage sensors are not activated, the 
interaction between Ca2+-binding and the channel pore is regulated by an allosteric factor 
C.  Furthermore, both voltage- and Ca2+ are coupled to channel gating through allosteric 





1.3 Mechanisms that convey diversity to BK current properties 
 BK currents can exhibit diverse properties, such different current kinetics, voltage 
sensitivities, and Ca2+ sensitivities.  Differences in current properties allow BK channels 
to regulate excitability in multiple tissues, as the electrical stimuli that activate BK 
currents in different tissues often occur over different time scales, voltage ranges, and 
frequencies.  BK current diversity can be attributed to multiple mechanisms, including 
alternative splicing of Kcnma1 (Butler et al., 1993; Xie and McCobb, 1998), auxiliary 
subunits (Brenner et al., 2000a; Yan and Aldrich, 2010), and phosphorylation (Reinhart et 
al., 1991; Yan et al., 2008). 
 Alternative splicing is one mechanism that accounts for BK current diversity 
(Butler et al., 1993; Ha et al., 2000; Shelley et al., 2013; Xie and McCobb, 1998).  
Alternative splicing increases protein diversity from a single gene, as editing of pre-
messenger RNA changes the encoded amino acid sequence, which can affect BK current 
properties (Shipston, 2001).  Within the C-terminus, there are four splice sites (S1-S4) 
(Figure 4).  Alternative splicing can directly affect BK current properties, which 
subsequently can modulate the excitability and function of cells such as those in the inner 
ear and adrenal gland (Ramanathan et al., 1999; Xie and McCobb, 1998).  However, the 
effect of specific exons on current properties can be dependent on inclusion or exclusion 
of other exons (Johnson et al., 2011; Rosenblatt et al., 1997; Shelley et al., 2013).  
Therefore, it is essential to carefully consider the splice variant background of the BK 
channel prior to experiments.  The alternative splice sites, the residues inserted at each 
splice site, and the effects of these residue sequences on current properties, can be found 


















Figure 4: Alternative splice sites with BK channel α-subunit 
Schematic of one BK channel α-subunit.  Alternative splice sites (S1-S4) are denoted by 









Site  Amino Acid Sequences 
Effect of amino acid sequences on 
BK current properties 












- 2, 3:  induce left-shifts in G-V, quickens 
activation kinetics (Xie and McCobb, 
1998) 
- 4:  left-shifts G-V, desensitizes channels 
to cAMP (Chen et al., 2005) 
3 (A)KPGKLPLVSVNQEKNSGTHILMITEL 
-Eliminates reduction in Hill Coefficient (Ha 












- -VYR, -VEDEC regulate BK trafficking 
to cell membranes (Singh et al., 2013) 
 
Table 1: BK channel alternative splice sites, possible amino acid sequences at each 








 Auxiliary β- and γ-subunit proteins are another mechanism underlying BK current 
diversity.  There are four β-subunit proteins (β1 - β4) whose expression levels are tissue-
dependent (Behrens et al., 2000; Brenner et al., 2000a; Meera et al., 2000).  Functionally, 
β-subunits generally enhance Ca2+-dependent activation of BK currents, and modulate 
current activation and deactivation kinetics.  Most work pertaining to physiological roles 
of BK β-subunits focuses on the β1 and β4 subunits.  β1 subunits, which are primarily 
associated with smooth muscle, but also found in brain, colon, uterus, and bladder via 
northern blot (Behrens et al., 2000; Brenner et al., 2000a; Dworetzky et al., 1994; Tseng-
Crank et al., 1996), generally cause an increase Ca2+ sensitivity.  Co-expression of the α 
and β1 subunits induces large (+40 to +78 mV) hyperpolarizing shifts in the G-V 
relationship of BK currents at multiple Ca2+ concentrations compared to the α-subunit 
alone (McCobb et al., 1995).  Also, genetic deletion of β1 subunits reduces the number of 
channel openings and amplitude of BK currents in response to Ca2+ spark events in 
arterial muscle (Brenner et al., 2000b).  In addition to increasing Ca2+ sensitivity, β1 
subunits also increase the time constants of activation (τAct) (Brenner et al., 2000a). 
 BK β4 subunits are primarily expressed in the brain but can also be detected in 
relatively low levels in tissues such as the heart, kidney, and lungs (Behrens et al., 2000; 
Brenner et al., 2000a; Meera et al., 2000).  The effects β4 subunits on BK current 
properties are complex, as β4 can confer differential effects on the G-V relationship of 
BK currents depending on the intracellular Ca2+ concentration.  When co-expressing BK 
α- and β4 subunits in symmetrical K+ solutions at low intracellular Ca2+ concentrations 




more positive potentials (Brenner et al., 2000a).  However, at Ca2+ concentrations greater 
than 10 µM, the β4 subunit shifts the G-V relationship in a negative direction, suggesting 
that at high Ca2+ concentrations, β4 subunits enhance Ca2+ sensitivity (Brenner et al., 
2000a).  In addition to complex effects on channel gating, β4 subunits also confer 
resistance to both iberiotoxin (IbTX) and charybdotoxin (CTX), two potent peptide toxin 
inhibitors of BK channels (Meera et al., 2000).  
 The β2 and β3 subunits, although less-studied physiologically than either β1 or 
β4, are distinct from the β1 and β4 subunits because they induce current inactivation. 
Inactivating BK currents exhibit a time-dependent reduction in current amplitude after 
initial activation (Solaro et al., 1995).  The inactivation conferred by β2 and β3 subunits 
is Ca2+-dependent, as the time constants of inactivation decrease as intracellular Ca2+ is 
increased (Wallner et al., 1999; Xia et al., 1999).  Furthermore, β2 subunits cause a 
hyperpolarizing shift in the G-V relationship at multiple Ca2+ concentrations, suggesting 
that β2 subunits still enhance Ca2+ sensitivity even though they promote current 
inactivation (Brenner et al., 2000a; Wallner et al., 1999; Xia et al., 1999).  The β3 subunit 
does not affect the G-V relationship in symmetrical K+ solutions (Brenner et al., 2000a), 
and confers less inactivation than the β2 subunit (Uebele et al., 2000).  
 In addition to β-subunits, evidence for auxiliary γ subunits has emerged within the 
last few years.  γ-subunits were first discovered in non-excitable prostate cancer cells, and 
co-expression of the BK α-subunit with the LRRC26 (γ1) subunit caused a 140 mV 
hyperpolarizing shift in G-V relationship (Yan and Aldrich, 2010).  Therefore, it was 
proposed that BK channels α-subunits co-expressed with γ1 could open at extremely 




negative shifts in the G-V relationship, are expressed in a tissue-dependent manner in 
several other tissues, including brain, testes, skeletal muscle, secretory glands, and colon 
(Yan and Aldrich, 2012). 
1.4 BK channel inhibitors 
 Physiological roles for BK channels are often established through 
pharmacological inhibition of BK currents.  Paxilline (PAX) and iberiotoxin (IbTX) are 
two commonly used BK channel inhibitors.  PAX is a lipophilic indole diterpene derived 
from the fungus Penicillium paxilli (Bilmen et al., 2002; Sanchez et al., 1996).  The 
inhibition constant (Ki), or concentration required to block 50% of the current, of PAX 
with BK channels was found to be 1.9 nM in conditions where there is 10 µM 
intracellular Ca2+ (Sanchez et al., 1996).  PAX is hypothesized to occlude the inner cavity 
of BK channels when the channels are in a closed state, and stabilize the channel in a 
closed configuration, therefore causing PAX to be termed a “closed-channel” blocker 
(Zhou and Lingle, 2014).  Glycine 311 in the S6 transmembrane domain has an essential 
role in conferring sensitivity of BK channels to PAX inhibition, as mutations of G311 
reduce the efficacy of PAX (Zhou et al., 2010).  Because G311 mutations shift the G-V 
relationship of BK currents to more negative potentials, it is hypothesized that G311 
causes the S6 domain to stay in a closed-channel conformation, which allows PAX to 
inhibit BK currents.  However, the effect of PAX is reduced or eliminated in conditions 
where the BK channel open probability is increased, such as when the membrane is 
depolarized or when intracellular Ca2+ is elevated (Sanchez et al., 1996; Zhou and Lingle, 




 PAX has been utilized to identify several roles for BK currents in the 
cardiovascular and nervous systems because of its membrane permeability.  In smooth 
muscle, PAX has been used to isolate BK currents from arteriolar smooth muscle (Wu et 
al., 2008), and causes a contractile response in mouse mesenteric arteries (Xu et al., 
2011), indicating that BK currents regulate vasoconstriction. Furthermore, hearts 
subjected to ischemia/reperfusion injury and then treated with PAX and NS1619, a BK 
channel agonist, were more infarcted than hearts only treated with NS1619 (Xu et al., 
2002).  This indicated that BK channel activation confers cardioprotection against 
ischemic injury.  In the brain, PAX has been used to identify the role of BK currents in 
the repolarization and afterhyperpolarization phases of neuronal action potentials (Faber 
and Sah, 2002).  Additionally, PAX was used to identify that BK current inhibition could 
serve as an anticonvulsant therapy, as PAX reduces firing activity in post-seizure 
neocortical neurons (Shruti et al., 2008).  
 PAX is beneficial compared to other BK antagonists, such as IbTX, because PAX 
is lower in cost, is membrane-permeable (Hu et al., 2001), and its effects are not 
dependent on accessory β-subunits (Brenner et al., 2005; Imlach et al., 2008).  However, 
PAX has several drawbacks, including its mechanism of action and its potential off-target 
effects.  The efficacy of PAX is largely dependent on the channels’ initial PO, as PAX 
inhibits BK currents more effectively when BK channels are initially closed (Zhou and 
Lingle, 2014).  Therefore, PAX may not be the most effective BK channel inhibitor in 
cell types that undergo constant depolarization, or exhibit consistent Ca2+ influx or 
intracellular Ca2+ release, all of which would increase the initial BK channel PO.  Also, 




an essential Ca2+ cycling protein that replenishes Ca2+ back into the sarcoplasmic 
reticulum (SR), at concentrations between 5 and 50 µM (Bilmen et al., 2002). 
 IbTX is a highly potent, membrane impermeable peptide toxin inhibitor of BK 
channels, with an IC50 of approximately 3.6 nM (Meera et al., 2000).  IbTX targets the 
extracellular face of BK channels and blocks the pore of the channel (Candia et al., 1992; 
Giangiacomo et al., 1992).  Like PAX, IbTX has also been used to identify the 
physiological role of BK channels in systems such as the brain (Sausbier et al., 2004; 
Shao et al., 1999), heart (Imlach et al., 2010), and bladder (Heppner et al., 1997; Herrera 
et al., 2000; Meredith et al., 2004).  The primary benefit of using IbTX is its high 
specificity and lack of known off-target effects.  However, there are also several 
drawbacks to using IbTX as a BK channel inhibitor.  In addition to being expensive 
compared to other BK inhibitors such as PAX or tetraethylammonium, and being 
membrane impermeable, the efficacy of IbTX is reduced by almost 1000-fold when the 
α-subunit is co-expressed with β4 subunits (Meera et al., 2000).  Therefore, IbTX may 
not be the most suitable BK channel inhibitor in tissues where β-subunit expression is 
unknown. 
1.5 BK currents regulate cardiovascular and neuronal function 
 The physiological roles for BK currents are generally established through the use 
of pharmacology or genetically-modified animals.  The physiological relevance of BK 
currents was originally discovered in Drosophilia, as deletion of the slowpoke (slo) gene 
eliminated a Ca2+-dependent K+ current and elongated the flight muscle action potentials 
(Elkins et al., 1986).  In mammalian systems, BK currents are best characterized in 




sparks, which are intracellular Ca2+ release events from ryanodine receptors (RyRs) on 
the sarcoplasmic reticulum (Nelson et al., 1995; Sausbier et al., 2005).  Upon activation, 
BK channel-mediated efflux of K+ causes membrane hyperpolarization and relaxation 
(Nelson et al., 1995), which allows BK currents to regulate blood pressure (Brenner et al., 
2000b; Nelson et al., 1995; Sausbier et al., 2005), urinary bladder function (Heppner et 
al., 1997; Meredith et al., 2004), cerebrovascular circulation (Filosa et al., 2006) and 
erectile function (Werner et al., 2005). 
In neurons, BK channels form complexes with voltage-gated Ca2+ channels 
(Berkefeld et al., 2006; Grimes et al., 2009), and upon activation BK currents contribute 
to the repolarization and afterhyperpolarization phases of neuronal action potentials 
(Storm, 1987), as well as neurotransmitter release (Wang et al., 2001).  This allows BK 
currents to regulate functions such as locomotor control (Imlach et al., 2008; Sausbier et 
al., 2004) and circadian rhythmicity (Meredith et al., 2006; Montgomery et al., 2013).  
Furthermore, mutations that disrupt BK channel function can alter neuronal excitability 
and manifest itself in conditions such as epilepsy (Du et al., 2005). 
1.6 Use of animal models to study BK currents  
 Although performing experiments on BK channels expressed in heterologous cells 
or on tissue extracted from animals can provide insight into roles for BK channels, in vivo 
experiments are still the best method for understanding physiological roles for BK 
channels.  Pharmacological BK inhibitors have been used to establish in vivo roles for 
BK channels, including in heart rate regulation (Imlach et al., 2010), locomotor function 
(Imlach et al., 2008), autonomic nerve activity (Kawada et al. 2010) and occurrence of 




difficult to administer over long periods of time, and could have off-target effects on 
other channels or proteins (Bilmen et al., 2002; Park et al., 2007).  Furthermore, 
inhibitors such as IbTX are not membrane permeable (Candia et al., 1992; Giangiacomo 
et al., 1992), which makes it difficult to target systems of interest in vivo.  
 To address these issues, genetically modified mice are often used to identify 
systemic roles for BK currents in vivo.  The generation of Kcnma1−/− mice, which lack 
expression of functional BK channels (Meredith et al., 2004; Sausbier et al., 2004), 
addressed several shortcomings associated with administering BK channel blockers into 
living organisms.  Genetic ablation of BK channels allows for the effects of chronic BK 
current inhibition to be studied while avoiding the off-target effects of BK channel 
inhibitors.  Additionally, Kcnma1−/− mouse tissue can serve as a valuable negative 
control for BK channel expression when trying to demonstrate novel BK channel 
expression in tissues.  Kcnma1−/− mice have been used to identify roles for BK currents in 
heart rate regulation (Imlach et al., 2010), circadian timekeeping (Meredith et al., 2006), 
urinary function (Meredith et al., 2004), and locomotor function (Meredith et al., 2004; 
Sausbier et al., 2004).  However, there are drawbacks to using genetically modified 
animals; deletion of BK channels may cause unwanted compensatory effects, such as 
overexpression of other channels or proteins, which may undermine the true 
physiological effect of eliminating BK channel function.  Also, because deletion of BK 
channels is global rather than tissue specific in these mice, expected observations such as 
elevated blood pressure may be due to unexpected mechanisms, such as changes in 
aldosterone levels, rather than strictly changes in vascular tone and relaxation (Sausbier 




Chapter 2: Specific Aims 
 The first aim of this dissertation focuses on the mechanism by which BK channels 
regulate heart rate.  BK channels are essential regulators of excitability in cells 
throughout the cardiovascular and nervous system, and within the last five years a novel 
role for BK channels in heart rate regulation was discovered (Imlach et al., 2010).  
However, the mechanism by which BK channels regulate heart rate is poorly understood.  
The goal of Specific Aim 1 is to elucidate the pathway by which BK channel inhibitors 
cause a reduction in heart rate.  We hypothesized that BK channels expressed in sinoatrial 
node cells, the heart’s predominant pacemaking cells, regulate heart rate.   
 The second aim of this dissertation focuses on the effect of non-synonomous 
single-nucleotide polymorphisms (SNPs) on human BK current properties.  SNPs are 
variations in nucleotide sequence that can lead to changes in the encoded BK channel 
amino acid sequence.  Approximately 100 non-synonymous SNPs in the gene that 
encodes BK channels (KCNMA1) have been identified, but few have been linked with 
disease or electrophysiologically characterized.  We hypothesized that SNPs linked with 
pathophysiological conditions or located in domains known to regulate Ca2+-dependent 







Chapter 3: General Methodology 
3.1 Equipment used for electrophysiology 
 Patch clamp recordings were performed using a Multiclamp 700B amplifier and 
Digidata 1440 (Axon Instruments, Sunnyvale, CA).  Data were acquired and analyzed 
using pClamp 10 (Axon Instruments).  Glass pipettes (TW150F-4, World Precision 
Instruments, Sarasota, FL) for recordings were pulled using a P-97 micropipette puller 
(Sutter Instruments, Novato, CA) and fire-polished using a MF-830 microforge 
(Narishige International, East Meadow, NY).  
3.2 Perforated patch action potential recordings from mouse sinoatrial node cells 
(SANCs) 
 Action potential experiments from mouse sinoatrial node cells was performed via 
the amphotericin B-based perforated patch configuration (Figure 5C) as previously 
described (Rae et al., 1991; Wu et al., 2009).  Amphotericin B (A9528, Sigma-Aldrich, 
St. Louis, MO) was resuspended in DMSO, and diluted in pipette solution at a 
concentration of 240 µg/mL.  For recordings, the Multiclamp 700B was set in zero-
current, current-clamp configuration, and data was acquired at 20 kHz.  Access 








Figure 5: Electrophysiology recording configurations 
BK currents and action potentials were recorded in one of three patch configurations; 
inside-out (A), whole-cell (B), or perforated-patch (C) configurations. In inside-out patch 
configuration (A), a patch of membrane containing BK channels is excised from the cell, 
exposing the intracellular side of the channel to the bath solution. This allows the BK 
currents to be recorded at different intracellular Ca2+ concentrations.  In whole-cell 
configuration (B), the cell membrane is ruptured, dialyzing the cytosol with pipette 
solution, but allowing for electrical access to the entire cell.  In perforated-patch 
configuration (C), amphotericin B (AmpB) in the pipette solution perforates the cell 
membrane, creating pores that only allow monovalent ions to permeate.  This allows for 
electrical access to the cell without dialyzing the cell cytosol with the pipette solution. 
 
  




3.3 Whole-cell patch recordings 
 Experiments recording native BK currents from mouse SANCs, as well as 
recording BK currents at nominal Ca2+ from HEK293T cells transfected with BK channel 
cDNA were performed in the whole-cell patch configuration (Figure 5B).  Solutions and 
recording parameters are listed in Chapter 4. 
3.4 Inside-out patch clamp recordings from HEK293T cells 
 BK currents were recorded at different intracellular Ca2+ concentrations using the 
inside-out patch configuration (Figure 5A).  Internal and external solutions used for 
experiments are listed in Chapters 4 and 5.  To determine the total Ca2+ required to reach 
desired free Ca2+ concentration, we utilized WebMaxC 
(http://web.stanford.edu/~cpatton/webmaxcS.htm). For calculations, we used a 
temperature of 20 °C, a pH of 7.2, and an ionic concentration of 0.16. 
3.5 HEK293T cell culture and transfections 
 HEK293T cells (CRL-11268, ATCC, Manassas, VA) were cultured on 35 mm or 
60 mm tissue culture dishes in media containing DMEM (Cat. #11995, Life 
Technologies), 10% fetal bovine serum (Cat #4315, Sigma-Aldrich), 1% 
penicillin/streptomycin (Cat. #30-002-Cl, Corning), and 1% L-glutamine (Cat. #25-005-
Cl, Corning).  Cells were maintained under sterile conditions in a 37 °C incubator 
supplied with 5% CO2.  BK channel constructs were transiently transfected into HEK 
cells using either Lipofectamine 2000 (Life Technologies, Grand Island, NY) or Trans-IT 
LT-1 (Mirus Bio, Madison, WI) transfection reagents.  Using Lipofectamine, a 1/5 ratio 




manufacturers’ recommended protocol.  Using LT-1, a 1.5/2 LT-1 ratio (µg/µL) was 
used, and transfections were performed according to the manufacturers’ recommended 
protocol.  Recordings were performed one to three days post transfection.  
3.6 DNA preparation 
 Plasmid DNA was prepared by Bing Jiang (Bioinnovatise, Rockville, MD). 
Plasmid DNA was transformed into DH5α competent cells (Cat. #18265-017, Life 
Technologies) according to the manufacturer’s protocol.  Plasmid DNA was isolated and 
purified using a plasmid purification kit (Cat. #12163, Qiagen, Venlo, Netherlands). 
DNA was stored in sterile water and frozen at -20 °C for transfections. 
3.7 Data analysis 
 The conductance of macroscopic currents obtained from inside-out patch 
recordings was determined by dividing the amplitude of the tail current 200 µs after the 
start of the repolarizing tail step by the voltage of the tail-step (Sweet and Cox, 2009). 
Conductance versus voltage (G-V) relationships were fit using either Origin 8.5 (Origin 
Lab, Northampton, MA) or Prism 5 (GraphPad, La Jolla, CA) to a Boltzmann fit 
equation: 
 
Activation and deactivation kinetics for inside-out patch recordings were fit to single 










Chapter 4: The role of BK channels in regulating cardiac 
pacemaking 
4.1 Introduction 
 Heart rate is regulated by the excitability of cells within the sinoatrial node 
(SAN), the heart’s primary pacemaker.  SAN cells (SANCs) are specialized cells within 
the right atrium that spontaneously evoke action potentials.  Within the last five years, the 
BK channel inhibitors paxilline (PAX) and iberiotoxin (IbTX) were shown to cause a 
reduction in heart rate in mice in vivo and in isolated rat hearts (Imlach et al., 2010). 
Although a previous study suggested that disruption of slo lowers heart rate in 
Drosophila melanogaster (Johnson et al., 1998), the results by Imlach et al. were the first 
to suggest that BK channels regulate mammalian heart rates.  However, the pathway by 
which BK channel inhibitors slow heart rate was not examined. 
 In this aim, we tested the hypothesis that BK channels expressed in SANCs 
regulate heart rate.  This hypothesis was based on results demonstrating that PAX and 
IbTX caused an acute reduction in isolated rat heart rates (Imlach et al., 2010), which 
suggests that the BK channels regulating heart rate are expressed within the heart.  To test 
this hypothesis, we investigated: 1) the effect of PAX on the electrocardiograms of mice 
in vivo, 2) the effect of BK channel inhibitors on mouse SANC firing rates and outward 
currents evoked from SANCs, 3) the expression of BK channels in mouse SANCs, and 4) 





4.2.1 BK channels in the heart 
 Although BK channels and currents are well-characterized in several cell types 
throughout the cardiovascular and nervous systems, the role of BK channels in the heart 
is less-studied.  Studies prior to 2010 did not indicate that BK channels regulate 
cardiomyocyte excitability, as IbTX, a membrane-impermeable BK channel inhibitor 
(Candia et al., 1992; Giangiacomo et al., 1992), did not alter ventricular myocyte action 
potentials (Takamatsu et al., 2003).  BK channel subunits were previously been detected 
in human and rodent hearts via northern blot (Behrens et al., 2000; Brenner et al., 2000a; 
Tseng-Crank et al., 1994) and western blot (Singh et al., 2013; Xu et al., 2002)(Figure 
30), and the majority of current work focuses on BK channels expressed in cardiac 
mitochondria.  BK channel expression has been detected in cardiac mitochondria 
(BKMito) (Singh et al., 2013), and functionally, BKMito are thought to mediate 
cardioprotection against ischemia/reperfusion injury; the BK channel activators NS1619 
and NS11021 reduce cardiac ischemic injury in rabbit (Xu et al., 2002), rat (Bentzen et 
al., 2009), and mouse (Singh et al., 2013) hearts.  Supporting this hypothesis, Kcnma1−/− 
mice are not afforded cardioprotection when subjected to treatment with NS1619 (Singh 
et al., 2013).  
 However, in 2010, a novel role for BK channels in heart rate regulation was 
reported (Imlach et al., 2010).  An acute reduction in heart rate was observed in wild-type 
(WT) mice but not Kcnma1−/− mice after PAX injection.  Also, both PAX and IbTX 
caused reductions in isolated rat heart rates (Imlach et al., 2010).  In combination, this 




rate, and regulate cardiac cell excitability.  Furthermore, because of IbTX’s lack of 
membrane permeability (Candia et al., 1992; Giangiacomo et al., 1992), this data 
suggested that membrane-bound BK channels mediate these effects.   
 Specific Aim 1 is designed to test the hypothesis that BK channels expressed in 
SANCs regulate heart rate. We formulated this hypothesis because SANCs are the 
predominant regulators of heart rate, and previous data suggests that BK channels 
expressed in the heart mediate the effects of BK channel inhibitors. 
4.2.2 SANC physiology 
 Heart rate in vivo is initiated and maintained by spontaneous action potentials 
evoked by SANCs, a specialized subset of myocytes residing within the right atrium 
(Mangoni and Nargeot, 2008).  Intrinsic excitability of SANCs is the result of finely 
controlled synergy between plasma membrane currents, and rhythmic Ca2+ release from 
the sarcoplasmic reticulum (SR)(Lakatta et al., 2010).  The SANC action potential 
consists of three main phases; diastolic depolarization (DD), the upstroke, and 
repolarization (Figure 6).   
 DD is the action potential phase that initiates SANC excitability.  During DD, the 
membrane spontaneously depolarizes from the maximum diastolic potential (MDP) to the 
threshold potential (Vth)(Mangoni and Nargeot, 2008)(Figure 6).  Although the 
mechanism that initiates the DD is highly controversial, it is thought that DD is the result 
of a synergy between a “voltage-clock” mechanism and a “Ca2+-clock” mechanism 
(Lakatta et al., 2010).  The voltage-clock mechanism of SANC automaticity is dependent 
on interaction of currents evoked by several different plasma membrane-bound ion 




hyperpolarization-activated cyclic nucleotide (HCN)-gated channels, activates robustly 
upon membrane hyperpolarization (DiFrancesco, 2006).  Upon activation, If causes 
membrane depolarization that activates T- and L-type Ca2+ current during the later stages 
of DD (Mangoni et al., 2003; 2006), which promotes further membrane depolarization 
until Vth is reached.  DD initiation via the Ca2+ clock occurs through rhythmic 
spontaneous local Ca2+ releases (LCRs) from the SR (Vinogradova et al., 2004), which 
activate the Na+/Ca2+ exchange current (INCX) on the plasma membrane and generates 
inward current that further promotes membrane depolarization that activates ICa 
(Bogdanov et al., 2001). 
 The upstroke phase of the SANC action potential follows DD.  The upstroke is 
primarily mediated by ICa,L current evoked by CaV1.2 channels (Mangoni et al., 2003).  
Inhibition of ICa,L with agents such as nifedipine has differential effects on pacemaker cell 
excitability, as nifedipine completely eliminates action potentials evoked by central 
SANCs obtained from rabbits, while just slowing the firing rate of peripheral SANCs 
(Kodama et al., 1997).  This is potentially due to variation in channel expression in 
different areas of the SAN.  INa is also thought to regulate the action potential upstroke in 
peripheral rabbit SANCs, since tetrodotoxin (TTX) does not affect the excitability of 
central SANCs, but reduces the upstroke velocity and firing rate of peripheral SANCs 
(Kodama et al., 1997).  INa is also essential in the upstroke of the mouse SANC action 
potential (Lei et al., 2004).   
 The repolarization phase of the SANC action potential is primarily attributed to 
activation of voltage-gated K+ currents, such as IK,r, IK,s, and to a lesser extent IT,o which 




(IT,o) current (Cho et al., 2003; Clark et al., 2004; Kodama et al., 1999).  IK,r, which is 
activated upon membrane depolarization, repolarizes the membrane and contributes 
towards setting the maximum diastolic potential (MDP) of the action potential.  
Inhibition of IK,r with agents such as E-4031 elongates the repolarization phase of the 
action potential and causes depolarization of the MDP (Clark et al., 2004; Kodama et al., 
1999).  Depolarization of the MDP by IK,r block is hypothesized to slow SANC firing by 
reducing hyperpolarization that activates If, as well as by causing voltage-dependent 
inactivation of ICa.  IK,s, which also contributes to the repolarization phase of the action 
potential, activates slower and deactivates faster than IK,r.  Although IK,s is not detectable 
in mouse SANCs (Cho et al., 2003; Mangoni et al., 2008), block of IK,s with 293B in 
porcine SANCs, which lack IK,r, also causes MDP depolarization and a suppression of 
excitability (Ono et al., 2000).  IT,o also contributes to the repolarization phase of the 
action potential, and block of IT,o with 4-AP causes elongation of the action potential 
duration and depolarization of the MDP (Boyett et al., 1998).  
 In vivo, SANCs automaticity is regulated by the autonomic nervous system 
(ANS), and vascular control of heart rate via the baroreceptor reflex.  The sympathetic 
and parasympathetic branches of the ANS innervate the SAN and modulate SANC firing 
through release of catecholamines (sympathetic) or acetylcholine (parasympathetic) 
(Figure 7).  The sympathetic nervous system regulates increases in heart rate through 
norepinephrine (NE) and epinephrine, which increase SANC action potential frequencies 
by activating β1-adrenergic receptors (Figure 7)(Mangoni and Nargeot, 2008). 




vagal nerve release of acetylcholine (ACh) which activates IK,ACh and binds to M2 
muscarinic receptors, which downregulates adenylate cyclase activity (Figure 7). 
 There is some evidence for BK channels in the sympathetic and parasympathetic 
branches of the ANS.  Reports indicate that BK currents are present in cardiac 
sympathetic nerves, as application of 20 nM IbTX to guinea pig sympathetic neurons 
caused a significant elongation (~13.5%) of action potential half-width (Ireland et al., 
1998), and application of 500 µM TEA to guinea pig sympathetic neurons lengthened the 
action potential duration by 38% (Locknar et al., 2004).  In parasympathetic neurons, BK 
channels are also implicated to regulate excitability, as 100 nM charybdotoxin (CTX) 
reduces K+ current amplitude by 35% (Xu and Adams, 1992), and 50 nM IbTX increases 
the action potential duration by 22% in rat dorsal vagal neurons (Pedarzani et al., 2000).  
Furthermore, local application of 2 µM IbTX to vagal neurons in anesthetized rabbits 
increased stimulation-induced ACh release, suggesting that BK block could cause heart 
rate decreases by increasing vagal nerve ACh release (Kawada et al., 2010).  Therefore, 
BK channels expressed in the ANS could act as a potential mechanism of heart rate 







Figure 6: Simplified model of SANC automaticity  
The SAN action potential consists of the diastolic depolarization (DD) (1), upstroke (2), 
and repolarization (3) phases.  DD is initiated by If and local calcium release (LCR) from 
the sarcoplasmic reticulum (SR).  LCRs activate INCX, which, along with If depolarize the 
membrane from the maximum diastolic potential (MDP) to the threshold potential.  As 
the membrane depolarizes during DD, ICa,T and ICa,L currents activate, further 
depolarizing the membrane to the threshold potential.  Upon reaching threshold, ICa,L 
further activates, causing the upstroke of the action potential.  During the upstroke, there 
is a large Ca2+ release from the SR.  The upstroke of the action potential causes 
inactivation of ICa,L and activation of IK, which causes membrane repolarization.  
Membrane repolarization re-activates If, which restarts DD.  When analyzing SANC 
action potentials, the duration of DD (DD duration), MDP, and action potential duration 
at 50% of the repolarization time (APD50) were all measured.  Figure adapted from 






Figure 7: Autonomic regulation of DD in SANCs 
Modulation of SANC firing is mediated by the sympathetic or parasympathetic nervous 
system.  Norepinephrine (NE) or an agonist such as isoproterenol (ISO) activate β-
adrenergic receptors and activate of adenylate cyclase (AC) through the G-protein 
coupled receptor pathway.  AC facilitates production of cAMP, which promotes 
activation of HCN4 channels.  cAMP also activates protein kinase A (PKA), which 
phosphorylates and promotes activation of voltage gated Ca2+ (CaV) channels.  Ca2+ 
influx enhances Ca2+ release from ryanodine receptors (RyRs), which also activates the 
Na+/Ca2+ exchanger (NCX).  Increases in If, ICa, and INCX all increase the rate of DD, 
which leads to an increase in heart rate. Muscarinic receptor agonists slow AP firing by 
inhibiting cAMP production through the αGi G-protein coupled receptors.  Figure 





 SANC action potential frequency is further controlled in vivo through the 
baroreflex, which is the homeostatic mechanism of maintaining arterial blood pressure 
through heart rate modulation (Lu et al., 2009).  Increases in blood pressure stretch 
baroreceptors in the carotid sinus and aortic arch, which increases afferent neuronal firing 
towards the brain stem and causes elevation in vagal discharge (Fadel et al., 2003).  This 
subsequently induces a decrease in both heart rate and blood pressure via increased 
parasympathetic tone. Conversely, reductions in blood pressure decrease stretch 
activation of baroreceptors, triggering catecholamine release in order to increase heart 
rate and blood pressure (Fadel et al., 2003). 
 Inhibition of BK channels with IbTX causes vasoconstriction and elevated 
vascular tone (Nelson et al., 1995), and mice with genetic deletions of the α or β1 subunit 
have elevated blood pressure (Brenner et al., 2000b; Sausbier et al., 2005); therefore, it 
could be hypothesized that pharmacological block of BK channels in vivo would cause 
increased vascular tone and blood pressure, and induce a compensational decrease in 
heart rate through the baroreflex.  However, PAX did not cause a significant increase in 
blood pressure in WT mice (Imlach et al., 2010)(unpublished data), suggesting that the 
mechanism underlying BK inhibitor-induced reductions in heart rate is not through the 
baroreflex. 
4.3 Materials and Methods 
4.3.1 Whole animal telemetry experiments and analysis 
 Wireless radio telemeters (ETA-F10, Data Sciences International, New Brighton, 




month-old FVBN/J mice to record electrocardiograms (ECGs). Dr. Ling Chen of the 
Small Animal Physiology Core at the University of Maryland School of Medicine 
performed surgeries.  Prior to surgeries, induction of anesthesia was performed in a 
sealed chamber using 2-3% isoflurane, with an oxygen flow-rate of 1-2 L/min.  After 
induction of anesthesia, mice were transferred to a heated surgical platform and 
anesthesia was maintained using 1-3% isoflurane at a flow-rate of 0.5-1.5 L/min.  To 
implant the transmitter, an incision was made through the skin on the neck, and surgical 
scissors were inserted into the incision to form a subcutaneous pocket using blunt 
dissection.  The transmitter body was placed into the pocket with the leads oriented 
rostral in a Lead II configuration.  The positive lead was capped using a piece of silicon 
tubing, and the lead was sutured to the surface of the abdomen, 1 cm to the right of the 
xiphoid process.  The negative lead was also capped and sutured to the muscle wall above 
the right clavicle.  The incision was sutured closed using 5-0 monofilament sutures, and 
further closed with staples.  After the procedure, mice were removed from anesthesia and 
allowed to recover on a heated platform.  Mice were given wetted food post-surgery and 
were injected subcutaneously with 0.05-0.1mg/kg of buprenorphine every 12 hours for a 
minimum of 72 hours post-operation, until the mice exhibited increased body mass and 
normal cage behavior.  Transmitters were turned on to record vital signals (ECGs, cage 
activity) to ensure full recovery from the procedure prior to experiments, and to ensure 
that adequate data could be acquired from the transmitters. 
 To determine the effect of PAX on heart rate, ECGs were recorded continuously 
and 8mg/kg PAX (#2006, Tocris, Minneapolis, MN) or the equivalent volume of DMSO 




experiment.  Heart rate measurements were calculated using the averages of five 10-
second segments during baseline (0.5 to 1 hour prior to PAX injection), and at denoted 
time intervals post injection.  Measurements were conducted during periods of home-
cage inactivity that were determined by the transmitter.  ECG analysis was performed on 
10-second segments of data collected when the mice were inactive at times representative 
of the baseline heart rate and the post-PAX injection heart rate.  ECG interval analysis 
was performed manually using pClamp 10 (Axon Instruments) or Ponemah (Data 
Sciences International). 
4.3.2 Mouse SANC isolation 
 Mouse SANCs were acutely isolated using a modified version of previously 
described methodology (Mangoni and Nargeot, 2001; Wu et al., 2009).  After euthanasia, 
mouse hearts were excised and rinsed in normal Tyrode’s solution containing (in mM): 
140 NaCl, 5.4 KCl, 5 HEPES, 5.5 glucose, 1.8 CaCl2, 1.0 MgCl2, with the pH adjusted to 
7.4 with NaOH.  The right atrium was dissected, cut into strips, and rinsed in low-Ca2+ 
Tyrode’s solution containing (in mM): 140 NaCl, 5.4 KCl, 5.5 HEPES, 5.5 glucose, 0.2 
CaCl2, 0.5 MgCl2, 1.2 KH2PO4, 50 taurine, and 1mg/mL BSA with the pH adjusted to 6.9 
with NaOH.  Tissue strips were then digested at 35 °C in low-Ca2+ Tyrode’s solution 
containing collagenase type II (LS004174, Worthington, Lakewood, NJ), elastase 
(LS002292, Worthington), and protease type XIV (P5174, Sigma-Aldrich, St. Louis, 
MO) for 25-30 minutes.  Tissue was then rinsed three times in 35 °C kraft-bruhe  (KB) 
solution, which contained (in mM): 100 potassium glutamate, 5.0 HEPES, 20 Glucose, 
25 KCl, 10 potassium aspartate, 2 MgSO4, 10 KH2PO4, 20 taurine, 5 creatine, 0.5 EGTA, 




tritrated using a wide-bore glass Pasteur pipette for 5-10 minutes until the strips became 
translucent and the KB solution became opaque.  Cells were stored for up to 8 hours at 
4°C.  10x stock solutions of normal Tyrode’s and low-Ca2+ Tyrode’s solution were kept 
at 4°C, while KB solution was stored in frozen aliquots at -20°C. 
4.3.3 SANC electrophysiology 
 Electrophysiological experiments were performed as described (Lai et al., 2014).  
For SANC action potential recordings, cells were continuously perfused with Tyrode’s 
solution at 0.7 mL/min at 35 ± 1°C.  SANCs were identified by their characteristic 
morphology, spontaneous contractions, and ability to spontaneously fire action potentials. 
Perforated-patch action potential recordings were acquired in current-clamp mode at 20 
kHz. Borosilicate glass pipettes (3-5 MΩ) were filled with (in mM): 130 potassium 
aspartate, 10 NaCl, 10 HEPES, 0.04 CaCl2, 2 MgATP, 7 phosphocreatine, 0.1 NaGTP, 
and 240 µg/mL amphotericin B, with the pH adjusted to 7.2 with KOH. Stable 
perforations were obtained within 5-13 minutes, and only SANCs with stable baseline 
action potential firing patterns were analyzed.  Frequency analysis was performed on 
one-minute segments of data using threshold-based detection methods, one minute after 
establishing stable perforation (baseline) or within 15 minutes after PAX application, at 
the time of the peak effect.  
 Action potential waveforms were analyzed according to the parameters previously 
described (Larson et al., 2013). Waveforms were analyzed in pClamp 10 (Axon 
Instruments).  Four to six action potentials were analyzed at times where the firing rate 
was representative of the baseline firing rate, or the after-PAX firing rates.  Action 




Microsoft Excel to determine specific intervals.  The diastolic duration was defined as the 
time interval between the maximum diastolic potential and the threshold potential (Vth) 
for the next action potential.  Vth was defined as the time at which 10% of the maximum 
dV/dt was reached.  The action potential duration at 50% repolarization (APD50) was 
defined as the time between Vth and the time at which 50% of the repolarization phase 
was reached.  
 Macroscopic BK current recordings were performed in the whole cell 
configuration at 30 ± 1°C during continuous perfusion of Tyrode’s solution at 1.25 
mL/min.  Data were acquired in voltage-clamp mode at 20 kHz.  Patch pipettes (1-3 MΩ) 
were filled with intracellular solution containing (in mM): 128 potassium aspartate, 6.6 
sodium phosphocreatine, 7 KCl, 1 MgCl2, 0.05 CaCl2, 10 HEPES, 5 EGTA, and 4 Mg-
ATP, with the pH adjusted to 7.2 with KOH.  Macroscopic currents were evoked from a 
holding potential of -75 mV, followed by 50 ms voltage steps from -130 to +60 mV.  All 
potentials were corrected for liquid junction potential (14.9 mV).  Currents were averaged 
from 4-5 voltage families at baseline and after 3 µM PAX application.  Series resistance 
was compensated at 60%, and only recordings where access resistance was < 10MΩ and 
changed less than 15% over the course of the experiment were used for analysis.  SANCs 
were distinguished from atrial cells based on the presence of If, which was evoked by 500 
ms hyperpolarizing voltage steps from -65 to -145 mV in the presence of 1 mM Ba2+, 
which blocks IK,ir (Cho et al., 2003; Liao et al., 2010).  Atrial cells had no If currents.  For 
representative If currents, the time-independent leak current was subtracted from the 





 Immunocytochemistry was performed as described (Lai et al., 2014). Mouse 
SANCs were fixed for 20 minutes with 2% paraformaldehyde, and then permeabilized 
and blocked with PBS containing 2 mg/mL BSA and 0.075% Triton-X100.  Cells were 
incubated overnight at 4°C in blocking solution containing 1:100 dilutions of mouse α-
HCN4 (N114/10, Neuromab, Davis, CA) and rabbit α-BK (APC-021, Alamone Labs, 
Jerusalem, Israel), washed in blocking solution, and incubated with 1:1000 dilutions of 
mouse Alexa 488 and rabbit Alexa 568 secondary antibodies (Life Technologies, Grand 
Island, NY) for two hours at room temperature.  Following PBS washes, cells were 
mounted onto glass slides using Vectashield (Vector Laboratories, Burlingame, CA). 
Images were collected at 40X using a LSM 5 Live confocal microscope (Zeiss, Jena, 
Germany). SANCs were identified by positive HCN4 expression.  Fluorescence intensity 
measurements were performed blind of genotype and analyzed using Zen 2009 Software 
(Zeiss).  Cell perimeters were outlined using the DIC image, and the average raw pixel 
intensity of each fluorophore was calculated within this area.  Acquisition was identical 
for all cells (gain = 700). 
 BK channel protein detection was amplified using a tyramide signal amplification 
kit (Cat. # T20932 or #T20934, Life Technologies).  Mouse SANCs were fixed for 20 
minutes with 2% paraformaldehyde, washed with PBS, and then permeabilized with PBS 
containing 2 mg/mL BSA and 0.075% Triton-X100.  Cells were treated with a biotin 
blocking kit (E-21390, Life Technologies).  Endogenous peroxidases were then quenched 
by incubating cells with 3% H2O2 for 30 minutes.  Cells were washed and then blocked 




1:1000 α-BK and 1:100 α-HCN4 antibodies.  Cells were washed 3x in PBS, and then 
incubated with 1:1000 tyramide-labeled Alexa Fluor 568 (BK) and Alexa Fluor 488 
(HCN4) antibodies (Life Technologies).  Following 3 PBS washes, cells were mounted 
onto glass slides using Vectashield, and imaged as described above. 
4.3.5 RT-PCR and BK channel cloning from SANCs 
 RT-PCR was performed by Joshua Whitt as previously described (Lai et al., 
2014). RNA was isolated from individual WT or Kcnma1−/− cells pooled from the SAN 
region using cell lysis buffer (Signosis, Santa Clara, Ca). RT-PCR was conducted on total 
RNA using the MyTaq One-Step RT-PCR kit (Bioline, Taunton, MA) and with gene 
specific primers according to the manufacturers protocol.  Reactions were performed on a 
PTC-200 Cycler, and BK and HCN4 PCR products (206 and 337 bp, respectively) were 
visualized on a 1.5% ethidium bromide-stained gel by electrophoresis. 
 RT-PCR product isolation and subcloning was performed by Bing Jiang 
(Bioinnovatise, Rockville, MD) as described below.  To clone BK channels from SANCs, 
individual SANCs were identified after perfusion with 35°C Tyrode’s solution, and at 
least 20 cells were pooled for lysis and RNA extraction.  BK channel cDNAs covering 
splice sites 1-4 (Shelley et al., 2013) were amplified via RT-PCR using the following 
sequences:  (Reverse transcriptase primers) 5’ TCTGTAAACCATTTCTTTTCT 3’ and 
5’ GCCGCTCTTCCTGAACGTACTT 3’; and PCR primers (both variants) (F) 5’ 
GAGTACAAGTCTGCCAACAG 3’ and (R) 5’ TCACCAGGGTCCGTATTAGG 3'.  
Products were gel-purified, subcloned, and two full-length products were obtained and 




#KF530043).  Sequences were subcloned into pcDNA3.1 for expression in HEK293T 
cells. 
4.3.6 HEK cell electrophysiology 
 To record macroscopic BK currents evoked from the cloned BK channels, BKVYR 
and BKQEERL cDNA was transiently transfected into HEK293T cells as described in 
Chapter 3.  For whole-cell recordings, the internal and external solutions, and voltage 
protocols were identical to those used with native SANCs.  For inside-out patch 
recordings, the internal (bath) solution was identical to that used for native SANC 
recordings, while the external (pipette) solution consisted of normal Tyrode’s solution 
excluding Ca2+.  The total Ca2+ concentration required to reach the desired free Ca2+ 
concentration for inside-out patch recordings was determined using WebMaxC, and 
solutions were buffered using 5 mM HEDTA.  For inside-out patch recordings, currents 
were evoked from a holding potential of -75mV, followed by 50 ms depolarizing voltage 
steps from -130 mV to +110 mV, followed by a hyperpolarizing voltage step back to -75 
mV.  Experiments using HEK293T cells were performed at room temperature. 
 If current recordings from HEK cells were performed on HEK293 cells stably 
expressing HCN4, the channel underlying If in SANCs.  Cells were provided by Dr. 
Cathy Proenza at the University of Colorado.  Cells were passaged and grown under 
selection with 100 µg/mL hygromycin.  Currents were evoked using 3 s hyperpolarizing 





 Data analysis was performed using pClamp 10 (Axon Instruments).  Significance 
was determined at P < 0.05 at the indicated tests.  Graphs were generated in Prism 5.0 
(GraphPad), and statistical analysis was performed using Origin Lab 8.5 (Origin Lab).  
Data are presented as means ± SEM. 
4.4 Results 
4.4.1 BK inhibitors reduce heart rate in vivo by slowing cardiac pacing 
 To determine the mechanism by which PAX slows heart rate in vivo in mice, we 
recorded heart rates and electrocardiograms (ECGs) from mice using wireless telemetry 
transmitters before and after injection of 8mg/kg PAX.  PAX is a lipophilic, membrane-
permeable compound that inhibits BK channels by stabilizing the channel in a closed 
state (Sanchez and McManus, 1996; Zhou and Lingle, 2014).  8 mg/kg PAX was utilized 
because of its previous use in experiments examining the role of BK channels in heart 
rate regulation (Imlach et al., 2010), and because 8 mg/kg PAX was demonstrated to 
cause impairment in motor function, a phenotype that is typically observed in Kcnma1−/− 
mice (Imlach et al., 2008).  Additional information on PAX can be found in Section 1.4. 
 Similar to the results of previous studies (Imlach et al., 2010), injection of PAX 
induced a significant reduction in heart rate in WT mice within two hours of PAX 
injection (Figure 8B).  Heart rate did not decrease when injecting WT mice with dimethyl 
sulfoxide (DMSO), the vehicle for PAX, or when injecting Kcnma1−/− mice with PAX 




injection in WT mice is due to BK channel inhibition, rather than off-target effects of 
PAX or DMSO.  
 Next, to identify the mechanism by which PAX alters cardiac conduction in vivo, 
we analyzed mouse ECGs before and after PAX injection. We examined specific 
intervals that provide insight on changes in cardiac conduction; the P-P interval (sinus 
rhythm), the R-R interval (interbeat interval), the P-R interval (conduction through the 
atrioventricular (AV) node, the Q-T interval (ventricular depolarization and 
repolarization), and the T-P interval (interval between ventricular repolarization and 
initiation of atrial depolarization).  Significant increases in the P-P, R-R, Q-T, and T-P 
intervals were observed after PAX injection (Figure 8C), suggesting that PAX could 
reduce heart rate by slowing cardiac pacing (P-P, T-P) and elongating ventricular 
depolarization and repolarization (Q-T).  The P-R interval was not significantly longer 
after PAX injection, indicating that AV conduction block did not contribute to the PAX-
induced heart rate reduction.  
 Next, we quantified the components of the cardiac conduction cycle that 
accounted for the PAX-induced heart rate reduction to determine what the reduction in 
heart rate was most attributed to.  To do this, we calculated the difference in each interval 
after PAX injection as a percent of the total change in the R-R interval.  The increase in 
P-P interval was after PAX injection was almost identical to the increase in the R-R 
interval after PAX, suggesting that the PAX-induced heart rate reduction was due to 
slowing of the sinus rhythm.  The increase in T-P after PAX injection accounted for 
56.5% of the total increase in R-R interval, also indicating that inhibition of BK channels 




for 35.7% of the total increase in the R-R interval, suggesting that although PAX may 
affect ventricular repolarization, it is not the predominant cause of the PAX-induced heart 
rate decrease.  The remaining 7.8% of the increase in R-R interval after PAX injection 
was due to the increase in P-R interval.  ECG intervals were not significantly different in 
Kcnma1−/− mice at baseline, indicating that genetic deletion of BK channels did not 
affect cardiac conduction.  In combination, because of the increase in both P-P and T-P 
intervals after PAX injection, our data suggests that PAX reduces mouse heart rates in 





Figure 8: PAX decreases heart rates of WT but not Kcnma1−/− mice   
(A) Structure of paxilline (Knaus et al., 1994).  PAX is a lipophilic BK channel inhibitor 
that stabilizies BK channels in a closed conformation.  (B) ECG waveforms were 
obtained from awake, freely moving animals using surgically implanted telemetry 
transmitters.  Heart rates were recorded at baseline and after intraperitoneal injection of 8 
mg/kg PAX or DMSO vehicle.  Heart rate was decreased in PAX-injected WT mice (n = 
13), but not Kcnma1−/− (n = 7) or WT mice treated with DMSO (n = 9, P = 10-9, factorial 
ANOVA). *Bonferroni post-hocs (WT PAX vs WT DMSO), 1 hr (P = 10-5), 2 hr (P = 
10-4), and 3 hr (P = 0.003) post-injection.  (C) Intervals from ECG waveforms of WT 
mice at baseline (n = 8), 2 hrs after PAX injection (n = 8), and Kcnma1−/− at baseline (n = 
3).  PAX-induced slowed heart rate is indicated by the elongated RR interval after PAX 
(P = 10-5, one-way ANOVA; *Bonferroni post-hoc, baseline vs PAX, P = 10-5).  The PP 
sinus rhythm was longer after PAX injection, but not in Kcnma1−/− mice (P = 10-5, one-
way ANOVA; *Bonferroni post-hoc, baseline vs PAX, P = 10-5).  The PR interval 
(atrioventricular node conduction) was not different after PAX injection or in Kcnma1−/− 
mice (P = 0.18, one-way ANOVA).  (D) Representative ECG recordings from a WT or 
Kcnma1−/− mouse during baseline conditions or after PAX injection.  R-R intervals 




4.4.2 Abolishment of BK channel function slows isolated mouse SANC firing rates 
 Because the predominant mechanism by which PAX decreases heart rate in vivo 
is a slowed the sinus rhythm, we hypothesized that BK channel inhibitors slow the firing 
rate of SANCs.  To test this hypothesis, we recorded action potentials from mouse 
SANCs in the presence of BK channel inhibitors and from Kcnma1−/− mouse SANCs.  A 
significant reduction in SANC firing rates occurred in the presence of 3 µM PAX (Figure 
9F).  This result was consistent with the PAX-induced slowing of cardiac pacing in vivo 
(Figure 8C), and further suggests that acute inhibition of BK channels slows heart rate by 
disrupting SANC firing rates.  
 To identify the mechanism by which PAX slowed the firing rate of SANCs, we 
analyzed the SANC action potential waveforms.  For this analysis, we examined diastolic 
depolarization duration (DD duration), the action potential duration at 50% repolarization 
(APD50), and the maximum diastolic potential (MDP) (Larson et al., 2013).  Interestingly, 
DD was elongated after application of PAX, as the DD duration was almost two times 
longer after PAX application (Figure 9G). In contrast, the APD50 and MDP were not 
significantly different (Figure 9H, Figure 9I). These results suggest that rather than 
regulating SANC action potential frequency by altering the repolarization phase of the 
action potential like other K+ currents in SANCs (Clark et al., 2004; Kodama et al., 
1999), BK channels modulate SANC firing frequency by affecting the DD phase of the 






Figure 9: PAX decreases SANC action potential firing frequency  
(A) Isolated mouse SANC in a perforated-patch configuration.  (B-D) Representative 
action potentials from a WT SANC during baseline conditions and after application of 3 
µM PAX (gray trace) (B, C), and WT and Kcnma1−/− (gray trace) SANCs during baseline 
conditions (D, E).  (F) Average action potential frequencies for WT SANCs during 
baseline recording conditions and during the peak effect of PAX (n = 7; P = 0.024, Paired 
t-test), and WT (n = 12) and Kcnma1−/− (n = 11) SANCs under baseline conditions (P = 
0.012, Mann-Whitney). Bpm (beats per minute), number of action potentials in one 
minute. (G) Diastolic depolarization (DD) durations for WT SANCs during baseline 




(n = 12) and Kcnma1−/− (n = 11) SANCs under baseline conditions (P = 0.012, Mann-
Whitney).  (H) Action potential duration at half maximum (APD50) measurements 
(baseline vs PAX, P = 0.262, Paired t – test; WT vs Kcnma1−/−, P = 0.157, unpaired t - 
test).  (I) Maximum diastolic depolarization (MDP) (baseline vs PAX, P = 0.93, Mann-
Whitney; WT vs Kcnma1−/−, P = 0.101, unpaired t - test).  PAX experiments were 
conducted on SANCs isolated from FVB/NJ background mice, while WT and Kcnma1−/− 
SANCs were obtained from C57BL/6J background mice.  Action potential parameters 








 To determine whether the effects of PAX on SANC firing were not due to off-
target effects of PAX on intracellular Ca2+ cycling proteins crucial to SANC 
automaticity, such as SERCA (Bilmen et al., 2002), we next tested the effect of 230 nM 
IbTX on SANC firing rates.  Because IbTX inhibits BK channels from the extracellular 
face and is membrane-impermeable (Candia et al., 1992; Giangiacomo et al., 1992), it 
can only inhibit plasma membrane-bound BK channels; therefore, effects of IbTX on 
action potential frequency would suggest that BK channels are on the plasma membrane 
of SANCs.  Perfusion of 230 nM IbTX induced a 29% reduction in WT SANC firing 
frequency (Figure 10A).  Correlating well with the PAX data, IbTX also elongated the 
DD duration but did not significantly alter the MDP or APD50 (Figure 10).  This result 
provides further evidence that BK channels regulate the firing rate of mouse SANCs, and 
suggests that BK channels on the plasma membrane regulate SANC excitability. 
 To further demonstrate that abolishment of BK currents reduces SANC firing 
rates, we examined the action potential frequencies of Kcnma1−/− mouse SANCs (Figure 
9D).  Surprisingly, although Kcnma1−/− SANCs have baseline heart rates similar to WT 
mice in vivo (Imlach et al., 2010; Sausbier et al., 2005)(Figure 8B), we found that 
Kcnma1−/− SANCs had lower baseline firing rates compared to WT SANCs (Figure 9F), 
and that the reduced firing rate was also associated with a longer DD duration compared 
to WT mice (Figure 9G).  This data was acquired in collaboration with Yuejin Wu, an 
expert in mouse SANC electrophysiology at the University of Iowa.  This data provides 
further evidence that BK channels are essential for regulating SANC action potential 
frequencies, and suggests that additional factors may provide heart rate compensation in 






Figure 10: Iberiotoxin decreases SANC firing rate  
(A) Average SANC firing frequency recorded in perforated-patch configuration during 
baseline conditions and after application of 230 nM IbTX (n = 9, P = 0.026, Paired t-
test).  (B) DD duration measurements during baseline conditions and after application of 
IBTX (n = 8, P = 0.041, Paired t - test).  (C) APD50 measurements during baseline 
conditions and after application of IBTX (n = 8, P = 0.18, Paired t - test).  (D) MDP 
measurements during baseline conditions and after application of IBTX (n = 8, P = 




4.4.3 Elevated activation of β-adrenergic receptor pathway precludes the effects of BK 
channel ablation on SANC firing  
 In vivo, heart rate is determined not only by the intrinsic firing rate of SANCs, but 
also by autonomic nervous system regulation of SANC excitability.  One mechanism that 
could cause Kcnma1−/− mice to have similar heart rates to WT mice is elevated 
sympathetic tone.  We tested the hypothesis that Kcnma1−/− mice may have normal heart 
rates in vivo due to elevated sympathetic tone by determining whether the PAX-induced 
reduction in SANC firing could be recovered by isoproterenol (ISO), a β-adrenergic 
receptor agonist.  In these experiments, baseline firing rates from WT SANCs were paced 
with 1 nM ISO, followed by co-application of 1 nM ISO and 3 µM PAX (Figure 11A).  
3µM PAX caused a significant reduction in the action potential frequency, suggesting 
that even under β-adrenergic signaling, BK channel inhibition causes a reduction in 
SANC firing (Figure 11C).  3 µM PAX also increased the DD duration in the presence of 
1 nM ISO without affecting the APD50 or MDP (Figure 11D). 
 Next, cells were treated with 3 µM PAX combined with a saturating dose (1 µM) 
of ISO (Wu et al., 2009) to determine whether saturating β-adrenergic receptor 
stimulation could reverse the PAX-induced reduction in firing.  1 µM ISO induced a 
complete recovery in the action potential frequency within 5 minutes (Figure 11C), as 
well as a reduction in DD duration to back baseline levels (Figure 11D).  In combination, 
these results suggest that the reduction in SANC action potential frequency caused by BK 
channel elimination may be functionally compensated for in Kcnma1−/− mice in vivo 




Figure 11: ISO compensates for the PAX-induced reduction in SANC firing rate  
(A) Representative experiment showing SANC action potential firing rate over time at 
baseline pacing (1 nM ISO), after application of 3 µM PAX to reduce firing rate, and 
after elevating ISO to 1 µM to recover firing rate.  (B) Representative action potential 
waveforms from A.  (C) Average action potential frequencies (n = 7, P < 10-4, one-way 
repeated measures ANOVA, *Bonferroni post-hoc, 1 nM ISO vs 1nM ISO + PAX, P = 
0.003; 1nM ISO + PAX vs 1 µM ISO + PAX, P = 0.001).  (D) DD duration (P < 10-5, 
one-way repeated measures ANOVA, *Bonferroni post-hoc, 1 nM ISO vs 1nM ISO + 
PAX, P = 10-4; 1nM ISO + PAX vs 1 µM ISO + PAX, P = 10-4).  (E) APD50  (P > 0.05, 
one-way repeated measures ANOVA). (F) MDP (P > 0.05, one-way repeated measures 
ANOVA, *Bonferroni post-hoc, 1 nM ISO vs 1nM ISO + PAX, P = 0.435; 1nM ISO + 





4.4.4 Characterization of BK currents from mouse SANCs 
 Our results suggest that the BK channels that regulate SANC firing are expressed 
on SANC plasma membrane, leading us to hypothesize that BK currents could be 
recorded from SANCs.  We tested this hypothesis by performing whole-cell voltage-
clamp recordings from SANCs in physiological solutions.  To isolate the BK current 
component of the initial total outward current (Figure 12A), we perfused 3 µM PAX onto 
SANCs for 2 minutes, and subtracted the residual current (Figure 12B) from the initial 
current to obtain the PAX-sensitive (BK) current (Figure 12B - inset).  If currents were 
recorded at the end of each experiment to identify the cell as an SANC (Figure 12C), 
since If is not present in atrial cells at the applied voltage steps (Marger et al., 2011). 
 A voltage- and PAX-sensitive current was detected in 5 out of 6 SANCs (Figure 
12D).  The PAX-sensitive current had a peak amplitude of 1.4 ± 0.3 pA/pF (Figure 12D).	 
To verify that current rundown did not contaminate the PAX-sensitive current, currents 
were recorded on additional cells in the presence of the vehicle (DMSO or Tyrode’s).   
No vehicle-sensitive current was observed in these cells (Figure 12E), further suggesting 
that the PAX-sensitive current in SANCs was actually a BK current. 
 If, which is evoked by HCN4 channels, is an essential inward current that initiates 
DD (DiFrancesco, 2006), and inhibition of If causes a reduction in SANC firing rates 
(Baruscotti et al., 2011).  To determine whether PAX-induced elongation of DD was not 
due to inhibition of If, we tested the effect of PAX on If in both native mouse SANCs, and 
in HEK293 cells stably expressing HCN4 channels.  3 µM PAX did not reduce If currents 
in either SANCs or HCN4-expressing HEK293 cells (Figure 13). These results 






Figure 12: PAX-sensitive currents in SANCs  
(A, B) Whole cell macroscopic currents were evoked from SANCs from a holding 
potential of -75 mV (with 5 mM EGTA in the intracellular pipette solution). 
Representative currents from baseline (A) and after 3 µM PAX (B). Inset in (B) is the 
PAX-subtracted current.  (C) If  current from the same cell.  If currents  (D) Average 
current density versus voltage for baseline currents (circles), after PAX (squares), and 
PAX-sensitive component (triangles).  Current values were obtained from steady-state 
levels at the end of the voltage step to prevent contamination from the initial inward 
current (n = 5 cells). Currents were normalized to cell capacitance (40.2 ± 4.6 pF, n = 6). 
(E) Average current density for the vehicle-sensitive control current (n = 6 cells).         
(F) The PAX-sensitive current increases with voltage, but the control current is negligible 
(Control vs PAX-sensitive current P = 10-5, repeated measures ANOVA, *Unpaired t-







Figure 13: PAX does not inhibit If  
Normalized current-voltage relationships for If currents recorded under baseline 
conditions and after application of PAX from SANCs (A) and HEK293 cells stably 
expressing HCN4 channels (B).  HEK293 cells were provided by Cathy Proenza.  If was 
evoked in a whole-cell patch configuration using 500 ms hyperpolarizing voltage steps in 
SANCs, and 3s hyperpolarizing voltage steps in HCN4-expressing HEK293 cells. I-V 
relationships in the +PAX condition were obtained 2 minutes post PAX perfusion.  n = 5 









4.4.5 BK channel expression in mouse SAN 
To characterize BK channel expression in SANCs, we performed reverse-
transcriptase PCR (RT-PCR) and immunocytochemistry to determine BK channel 
transcript and protein levels, respectively.  First, RT-PCR was performed on WT and 
Kcnma1−/− mouse SANCs by Joshua Whitt.  BK channel RNA was positively identified 
from SANCs by designing primers that specifically flanked regions of the channel that 
were deleted Kcnma1−/− mice.  HCN4 was amplified as a control to demonstrate that 
isolated cells were SANCs.  BK channel RT-PCR products were detected from WT 
SANCs, but not Kcnma1−/− SANCs or WT SANCs in the absence of reverse transcriptase 
(Figure 14A). This result indicates that BK channel transcripts are present in SANCs. 
Next, to visualize BK channel expression in SANCs, conventional 
immunocytochemistry was utilized on isolated WT and Kcnma1−/− mouse SANCs.  Cells 
were co-labeled with a rabbit polyclonal BK channel antibody that recognizes the 
intracellular –COOH terminus of the BK α-subunit, and a mouse monoclonal antibody 
against HCN4 channels to positively identify SANCs (Figure 14B).  BK channel 
expression levels were quantified in SANCs by calculating the average pixel intensity for 
BK and HCN4 fluorescence for each cell.  WT SANCs exhibited higher BK signal 
intensities than cells isolated from Kcnma1−/− mice, indicating that BK channel protein is 
expressed in SANCs (Figure 14C).  BK expression was also found to overlap with HCN4 
expression (Figure 14B), suggesting that BK expression occurs on SANC plasma 
membranes. 
Although BK channel signal intensity was appreciably higher in WT SANCs 




expression signal intensity for better visualization, a tyramide signal amplification (TSA) 
kit was used, which amplifies the signal through a catalytic reaction between horseradish 
peroxidase (HRP) and a tyramide-labeled secondary antibody that becomes activated 
upon treatment with H2O2.  The signal intensity in WT cells treated with primary BK 
channel antibody was significantly higher than the intensity of WT cells treated only with 
the secondary antibody (Figure 14E).  These results further demonstrate that BK channels 





















Figure 14: Detection of BK channels in SANCs  
(A) RT-PCR from WT and Kcnma1−/− SAN (performed by Joshua Whitt).  The 
specificity of BK expression was verified using N-terminal primers located within the 
deleted Kcnma1−/− sequence. A 206 bp product was amplified from WT SAN, while no 
product was amplified from Kcnma1−/− SAN (n = 2).  HCN4 was amplified from both 
WT and Kcnma1−/− SAN (337 bp). (B) Confocal images from WT and Kcnma1−/− 
SANCs incubated with α-BK (green) and α-HCN4 (red) antibodies. Images collected 
under equivalent gain settings. (C) Average pixel intensity values for α-BK fluorescence 
in SANCs (WT, n = 5 cells and Kcnma1−/−, n = 5) and atria (WT, n = 4 cells and 
Kcnma1−/−, n = 3). In SANCs, WT BK expression was increased compared to Kcnma1−/− 
(P = 0.04, unpaired t- test).  (D) Tyramide signal amplification of BK signal (red) from 
WT SANCs.  HCN4 (green) immunofluorescence was performed as in B.  (E) Average 
pixel intensity values for BK signal (n = 21 cells) versus no primary control (n = 20; P 





4.4.6 Characterization of currents evoked by BK channels cloned from mouse SANCs 
 Since we could not characterize Ca2+-dependent activation from native SANCs 
because we could not increase the intracellular Ca2+, we characterized current properties 
of BK channels cloned from SANCs.  We first identified the BK channel splice variants 
expressed in SANCs by amplifying BK channel transcripts from single SANCs by RT-
PCR, and then characterized BK currents after expressing the resulting BK channel 
cDNAs in HEK293T cells.  Two cDNA products were obtained from SANCs that lacked 
alternative exons at splice sites 1-3, but differed in the alternative exon at splice site 4 (–
QEERL and -VYR).  These constructs were identical to constructs previously cloned by 
our lab from brain (Shelley et al., 2013) and bladder (unpublished data). 
 First, we determined whether BKQEERL and BKVYR currents exhibited similar 
properties to the native BK current recorded from SANCs.  HEK293T cells were 
transfected with BKQEERL or BKVYR variants tagged with a yellow fluorescent protein 
(YFP) to positively identify cells with BK expression, and BK currents were recorded in 
whole-cell patch configuration. Both BKQEERL and BKVYR currents had similar I-V 
relationships to native BK currents from SANCs (Figure 15C).  This result suggests that 
native SANC BK currents were small and activated at more positive potentials than 
expected due to the high concentration of EGTA (5 mM), and low resulting Ca2+ 
concentration (1.9 nM) in the internal pipette solution.  
 Next, to further characterize the properties of currents evoked by BKQEERL and 
BKVYR channels, we recorded BK currents at nominal, 1 µM, and 50 µM Ca2+ in an 
inside-out patch configuration. The normalized I-V relationship for both BKQEERL and 




voltage at half maximal activation (V1/2) for both constructs were similar at each Ca2+ 
concentration (Figure 15B).  Although these variants contained different alternative 
exons at the COOH-terminus, it was not surprising that the BKQEERL and BKVYR currents 
exhibited similar properties in physiological K+ solutions, as other studies performed in 
symmetrical K+ solutions suggest that BKQEERL and BKVYR have similar G-V 
relationships, activation and deactivation kinetics in multiple Ca2+ concentrations (Joshua 







Figure 15: Characterization of currents produced by BK channel variants cloned 
from SANCs  
Macroscopic currents were evoked from HEK293T cells expressing BKVYR or BKQEERL 
cDNAs. Recordings were performed in physiological K+ (5.4 mM external/135 mM 
internal).  (A) Representative current traces from inside-out patches at nominal, 1 µM, 
and 50 µM free Ca2+.  Currents were recorded using 50 ms depolarizing voltage steps 
from -130 mV to +110 mV.  (B) Average normalized I-V relationships from inside-out 
patch recordings from BKVYR and BKQEERL channel variants (I/Imax[+110mV]).  n = 6-9 
patches per condition.  Current amplitudes were obtained from the end of the steady-state 
current at the end of the depolarizing voltage step.  (C) Average normalized I-V 
relationships (I/Imax[+60mV]) recorded in whole-cell configuration with the same 
intracellular and bath solutions used for SANCs in Figure 12.  BKVYR and BKQEERL, n = 
9-10 cells for each channel variant.  The PAX-sensitive current from SANCs in Figure 12 
was replotted as I/Imax for comparison (n = 5 SANCs).  The voltage protocol was identical 




4.5 Discussion  
 In the heart, BK channels mediate cardioprotection against ischemic injury 
(Bentzen et al., 2009; Singh et al., 2013; Xu et al., 2002), and regulate heart rate in 
rodents (Imlach et al., 2010) . However, roles for BK channels in regulating cardiac cell 
excitability had not been reported prior to this work.  This chapter describes a novel role 
for BK channels in mediating the automaticity of SANCs, the primary cardiac 
pacemaking cells (Lai et al., 2014).  We demonstrate that: 1) pharmacological inhibition 
of BK channels in vivo reduces heart rate in mice (Figure 8), 2) BK channel inhibitors 
and genetic deletion of BK channels reduce the spontaneous firing rate of isolated 
SANCs (Figure 9, Figure 10), 3) β-adrenergic receptor agonists can recover the reduction 
in firing rate caused by PAX (Figure 11), 4) BK channel transcripts and protein can be 
detected from SANCs (Figure 14), and 5) BK currents can be detected from native 
SANCs (Figure 12).  We also characterized properties of BK currents evoked by channels 
cloned from SANCs and found that they exhibit similar I-V relationships to the native 
SANC BK current (Figure 15).  In combination, these results support the hypothesis that 
BK channels regulate heart rate by mediating the firing rate of SANCs. 
4.5.1 Is heart rate compensated for in Kcnma1−/− mice? 
 Although PAX caused a reduction in heart rate in WT mice, the baseline heart 
rates of Kcnma1−/− were similar to those of WT mice (Figure 8).  This result is consistent 
with others that reported the heart rates of Kcnma1−/− mice (Imlach et al., 2010; Sausbier 
et al., 2005).  Interestingly, Kcnma1−/− SANCs had lower intrinsic firing rates compared 
to WT cells, which suggests that the heart rates of Kcnma1−/− mice may be compensated 




automaticity, such as CaV1.3 or HCN4, have similar heart rates to WT mice when 
sympathetic tone is increased pharmacologically or through activity (Herrmann et al., 
2007; Platzer et al., 2000).  This suggests that Kcnma1−/− mice could potentially have 
normal heart rates due to elevated sympathetic tone.  Our data correlate well with this 
hypothesis, as a saturating concentration of ISO can recover the detrimental effect of 
PAX on SANC action potential frequency (Figure 11).  Further experiments, such as 
catecholamine measurements, could help further determine whether sympathetic tone is 
elevated in Kcnma1−/− mice. 
4.5.2 BK current inhibition reduces excitability in SANCs 
 Interestingly, the reduction in SANC firing observed after BK current inhibition 
contradicts the general result of BK current abolishment in smooth muscle and neurons, 
which is an increase in excitability (Heppner et al., 1997; Meredith et al., 2004; 2006; 
Nelson et al., 1995).  Previous reports indicate that BK currents can have multiple effects 
on cell excitability, as expression of gain-of-function BK channels can both enhance and 
reduce neuronal excitability, and pharmacological inhibition of BK currents can suppress 
excitability in a mouse seizure model (Montgomery and Meredith, 2012; Shruti et al., 
2008).  Our results are consistent with the reduction in excitability observed in other 
cardiac pacemaking cells after block of Ca2+-activated K+ channels, such as intermediate-
conductance (IK) and small-conductance (SK) channels (Chen et al., 2013; Weisbrod et 
al., 2013).   
 Diastolic depolarization (DD) is heavily dependent on synergy between both 
voltage- and Ca2+-clock mechanisms.  The phenotype observed with inhibition of other 




excitability due to elongation of DD, is consistent with our results.  In previous studies, 
inhibition of IK currents causes MDP depolarization.  This decreases pacemaker cell 
excitability by reducing the hyperpolarizing drive that activates If at the beginning of DD, 
which precludes activation of currents that participate in late DD, such as ICa,L (Weisbrod 
et al., 2013).  Interestingly, DD was elongated after genetic or pharmacological inhibition 
of BK currents, even though we did not observe a significant depolarization of MDP.  BK 
currents are activated in other cell types by coupling to Ca2+ sourced from CaV channels 
or SR Ca2+ release (Berkefeld et al., 2006; Nelson et al., 1995), both of which play 
prominent roles in DD.  Therefore, inhibition of BK currents that activate during DD, 
which would depolarize the membrane, may facilitate inactivation of currents that are 
prevalent during DD, such as INa or ICa (Kodama et al., 1997; Lei et al., 2004).  
Alternatively, BK currents could be activated by the bulk Ca2+ transient that occurs 
during the upstroke of the action potential.  Therefore, inhibition of BK currents could 
potentially affect the rate of membrane hyperpolarization that activates If, which 
subsequently could reduce excitability by reducing the rate of DD. 
4.5.3 Characterization of native BK currents from SANCs 
 Characterizing the properties of native BK currents, such as the voltage-
dependence of activation at increasing Ca2+, was not possible because of the high 
concentration of intracellular EGTA (5 mM) required to maintain recording integrity 
(Figure 15).  5 mM EGTA would chelate internal Ca2+ to a calculated concentration of 
1.9 nM, which would not be sufficient to activate BK currents at physiological DD 
potentials based on our cloned channel BK current recordings (Figure 15B).  Attempts at 




were unsuccessful.  We addressed this issue by characterizing BK currents evoked by 
cloned BK channels.  We first demonstrated that cloned BK channels with at 1.9 nM 
intracellular Ca2+ exhibited a similar I-V to native SANC BK currents (Figure 15C), 
indicating that the native BK current, despite being small and activating at positive 
potentials, was actually a BK current.  At elevated Ca2+ (50 µM), which is a potential 
local Ca2+ concentration at Ca2+ spark sites or adjacent to voltage-gated Ca2+ channels 
(Berkefeld et al., 2006; Fakler and Adelman, 2008; Perez et al., 2001), BK currents began 
to activate at the hyperpolarized potentials that occur during DD (Figure 15B).  This data 
suggests that BK currents in SANCs could be activated during DD by Ca2+ from either 
through voltage-gated Ca2+ channels or RyRs.  Future experiments could be designed to 
determine the Ca2+ source that activates BK currents during DD (Section 4.6). 
4.5.4 BK currents may regulate ventricular myocyte excitability 
 BK expression has previously been reported in ventricular myocytes (Singh et al., 
2013; Xu et al., 2002), but these reports do no implicate BK channels in regulating 
ventricular myocyte excitability.  IbTX was previously reported to not to affect rat 
ventricular myocyte action potentials (Takamatsu et al., 2003).  Our ECG data suggests 
that BK channel inhibition does affect ventricular myocyte excitability, as the Q-T 
interval was prolonged by PAX (Figure 8C).  A potential explanation for the conflicting 
data may be β4-subunit expression, as β4 has been detected in the heart (Behrens et al., 
2000; Brenner et al., 2000a; Meera et al., 2000) and conveys IbTX-resistance to BK 
channels at 100 nM (Meera et al., 2000; Takamatsu et al., 2003).  A more thorough 




myoctyes would be required in order to understand the mechanism by which PAX 
elongates the Q-T interval. 
4.5.5 Model of BK current regulation of SANC firing 
 Our data indicates that eliminating BK currents reduces SANC excitability and 
cardiac pacing in vivo by elongating the DD duration.  This finding contradicts the 
general phenotype observed with abolishment of BK channel function, as 
pharmacological inhibition and genetic ablation of BK currents generally increases cell 
excitability (Heppner et al., 1997; Meredith et al., 2004; 2006; Nelson et al., 1995).  BK 
currents in neurons, and cells such as urinary bladder smooth muscle cells, usually 
contribute to the repolarization and afterhyperpolarization phases of the action potential.  
In SANCs, repolarization is mediated by fast (IK,r) and slow (IK,s) delayed rectifier K+ 
currents and the transient outward (IT,o) K+ current.  Pharmacological inhibition of these 
K+ currents causes elongation of the APD50 and depolarization of the MDP, which are 
hypothesized to reduce excitability by reducing If (Boyett et al., 1998; Clark et al., 2004; 
Kodama et al., 1999; Ono et al., 2000).  Although ablating BK channel function reduces 
the action potential frequency of SANCs, only a modest increase in the APD50 was 
observed, which was not statistically significant (Figure 9H).  This finding suggests that 
BK currents may not be heavily involved in regulating SANC repolarization, and 
indicates that BK channels regulate SANC excitability by affecting a different phase of 
the action potential. 
 BK current inhibition does not induced depolarization of the MDP (Figure 9I), 
which suggests that BK currents would not regulate the initial phases of DD that are 




caused by BK currents, is required to facilitate If activation and recovery from 
inactivation of ICa and INa.  Based on our recordings obtained from BK channels cloned 
from SANCs, BK activation at the membrane potentials that encompass DD would 
require elevation of intracellular Ca2+ (Figure 15B).  Two potential Ca2+ sources that 
could couple to BK channels and are active during the later stages of DD are membrane-
bound voltage-gated Ca2+ channels and local Ca2+ release from the SR (Figure 6).  Since 
BK currents would hyperpolarize the membrane, it might be expected that inhibition of 
BK currents that activate during the later stages of DD due to elevation of Ca2+ would 
cause membrane depolarization.  This could potentially prevent recovery of inactivation 
of ICa or INa, as well as reduce the hyperpolarizing force that would activate If after the 







Figure 16: Proposed model of BK current regulation of SANC automaticity 
BK current inhibition reduces SANC excitability by increasing the DD duration.  Our 
data from BK channels cloned from SANCs suggests that coupling of BK channels to 
CaV and/or RyR is required for BK channel activation during DD.  Inhibition of BK 
currents with PAX may facilitate an increase in the DD duration by subsequently 
reducing If current, or preventing ICa or INa from recovering from inactivation, all of 






4.6 Future Studies 
 Our data suggests that BK channels regulate the DD phase of the action potential, 
but the mechanism is still unclear.  To determine the Ca2+ sources that activate BK 
channels during DD, it would be interesting to record BK currents in a perforated patch 
configuration in the presence of L-type Ca2+ channel inhibitor isradipine (Mangoni et al., 
2006), or ryanodine, which blocks SR Ca2+ release from RyRs and would subsequently 
preclude BK current activation (Nelson et al., 1995; Vinogradova et al., 2002).  
Recording currents in perforated patch would allow for intracellular Ca2+ cycling to be 
maintained during experiments.  By determining whether BK currents are abolished in 
the presence of either Ca2+ source inhibitor, we could determine the mechanism by which 
BK currents are activated. 
 Another future study would be to determine whether BK channels other than on 
the plasma membrane in SANCs regulate action potential frequency.  The magnitude of 
PAX-effect on SANC firing was greater (57%) than the effect of IbTX (29%), suggesting 
that BK channels localized in other areas besides the plasma membrane, such as in 
mitochondria (Singh et al., 2013), may regulate SANC automaticity.  It is unknown 
whether BK channels are expressed in the mitochondria of SANCs, so further 
characterization of SANC mitochondria would be required.  If BK channels were found 
in SANC mitochondria, to test whether they regulate SANC firing, IbTX could be 
applied to SANCs first to block plasma membrane-bound BK channels, followed by PAX 
application to block intracellular BK channels.  A further reduction after PAX application 




 A third future study would be to explore the role of BK β-subunits in SANC 
function.  β-subunits, such as β4, have been detected in cardiac tissue and are generally 
linked with increases in Ca2+ sensitivity (Brenner et al., 2000a; Meera et al., 2000).  In 
our experiments, BK currents evoked by the α-subunit alone begin to activate at the 
potentials that encompass DD at high Ca2+ (50 µM), and β-subunit co-expression may 
cause BK current activation to become more robust in this potential range.  Furthermore, 
β4-subunit expression may contribute to reduced effect of IbTX on SANC firing 
compared to PAX.  Future experiments may consist of characterizing BKQEERL and 
BKVYR in physiological solutions while co-expressed with β-subunits, as well as 
characterizing β-subunit expression in isolated SANCs. 
4.7 Summary 
 In this chapter, we identified BK channels as novel regulators of SAN function. 
Inhibition of BK channels was demonstrated to reduce cardiac pacing in mice in vivo, and 
decrease the firing rates of isolated mouse SANCs.  BK channel protein and transcripts 
were identified in isolated SANCs, and the native BK current properties obtained from 
SANCs were similar to those of currents recorded from BK channels cloned from SANCs 
and expressed in HEK293 cells.  Our findings indicate that BK channels are essential 
regulators of intrinsic SANC automaticity, and that BK channels modulate SANC firing 




Chapter 5: Regulation of BK currents by single nucleotide 
polymorphisms 
5.1 Introduction 
 Diversity of BK current properties can be attributed to multiple factors, including 
alternative splicing and auxiliary subunits.  However, the effect of single-nucleotide 
polymorphisms (SNPs) on BK current properties has not been extensively studied.  SNPs 
are a type of genetic variation that cause approximately 90% of human sequence 
variations (Collins et al., 1998), and SNPs in ion channels have previously been 
associated with conditions such as epilepsy (Klassen et al., 2011), schizophrenia (Lee et 
al., 2013), sinus node dysfunction (Baig et al., 2010), and obesity (Jiao et al., 2011). 
 There are 155 SNPs in the human KCNMA1 sequence; however, only 
approximately 63% (99/155) of these are non-synonymous SNPs, or SNPs that affect the 
encoded amino acid sequence.  Furthermore, only two polymorphisms have been 
characterized or linked to pathological conditions.  The first polymorphism (D434G) is 
associated with epilepsy and dyskinesia in humans (Du et al., 2005).  D434G, which is 
the RCK1 domain in the BK channel C-terminus, causes a +100 mV negative shift in the 
conductance-voltage (G-V) relationship and significantly increases the single channel 
open probability of the channel (Du et al., 2005; Yang et al., 2010).  The second SNP 
(A138V) is in the intracellular S0-S1 linker region and has been linked with autism.  
Although a cell line isolated from a patient with the A138V SNP had a 70% reduction in 
BK current compared to control patients (Laumonnier et al., 2006), the properties of the 
A138V BK current, such as the voltage-dependence, Ca2+ sensitivity, or current kinetics 





 Because KCNMA1 SNPs have been linked to epilepsy and autism, and there are 
98 non-synonymous SNPs in KCNMA1 that have not been characterized, we predicted 
that SNPs may regulate BK current properties.  We hypothesized that SNPs linked with 
pathophysiological conditions or located in domains of the C-terminus previously 
demonstrated to regulate Ca2+-dependent activation would alter BK current properties.  
To test this hypothesis, we assembled a list of all known SNPs in KCNMA1, and 
identified SNPs that were disease-linked or in regions of the C-terminus reported to 
regulate BK current properties.  Next, we characterized BK currents evoked from BK 
channels containing SNPs in symmetrical and physiological K+ solutions.  Then, to 
identify the effect that SNPs may have on BK currents elicited by physiological stimuli, 
we measured the amplitudes of currents evoked from BK channels containing SNPs in 
response to different action potential waveform commands.   
5.2 Methodology 
5.2.1 Synthesis of human BK (hBK) channel variant 
 For experiments involving SNPs, we used the human BK (hBK) channel clone, 
which does not contain alternative exons at splice sites one through three (S1-S3), and 
contains a residue sequence that ends in –QEERL at splice site four (S4, Table 2).  This 
variant was chosen due to its expression in multiple tissues, including vascular smooth 
muscle and brain (Dworetzky et al., 1994; McCobb et al., 1995).  To construct a 
“humanized” clone for expression in HEK cells with this particular exon combination, 
referred to as “hBK” throughout this study, we first converted an existing mouse clone 
(mBKZero) to a human clone (hBKZero) by replacing 8 amino acids that differ in the mouse 




fragment (mBKQEERL, F4) into hBKZero to create a clone with the indicated exon 
combination (hBK, Table 3, Figure 17).  Upon constructing hBK, further site directed 













Table 2: List of BK channel variants used and the amino acid sequences at each 
alternative splice site 
mBKQEERL and hBK sequences were identified by Jessica Lu.  hBKZero and hBKSRKR 
were derived from mouse constructs that were identified in our lab’s previous publication 
(Shelley et al., 2013).  
  
Construct S1 S2 S3 S4 
mBKQEERL _ _ _ -KYVQEERL 
































21 G S GGC AGC 
23 G _ GGT _ 
42 _ S _ AGC 
151 V A GTG GCG 
684 V I GTC ATC 
696 R K AGG AAG 
704 P S CCA TCA 
1158 P Q CCG CAG 
 
Table 3: Amino acid differences between mBKZero and hBKZero   
Table 3 describes the residue variation between mouse and human BKZero channel 
variants (identified by Jessica Lu), and the base pair substitution required to generate the 










Figure 17: Strategy for constructing hBK channel variant 
To generate hBK, we first generated the hBKZero clone.  hBKZero was generated by 
aligning a consensus human BK channel sequence with the mouse BKZero (mBKZero) 
clone (Shelley et al., 2013). Mouse and human BK channel sequence variance was 
determined by Jessica Lu.  Eight amino acid differences were identified between the 
consensus human BK channel sequence and mBKZero.  These residues were mutated in 
mBKZero via site-directed mutatgenesis in order to generate hBKZero (Table 2).  Upon 
synthesis of the hBKZero variant, hBKZero sequence was then aligned with other human 
BK channel sequences found in GenBank and described in other publications to identify 
the sequence most frequently occurring in human tissue.  This sequence was most similar 
to our lab’s mBKQEERL construct (Figure 17), which contains no alternate exon at S3, and 
contains the residue sequence at S4 ending in –QEERL.  Base pairs 3351 – 8331 (F4) 
were ligated from mBKQEERL into hBKZero, replacing base pairs 3351 – 8412 (F2) to 
synthesize a construct with an appropriate alternate exon combination, which is the hBK 
construct.  Additional site-directed mutatgensis (P1158Q) was then performed due to 






5.2.2 Identification of SNPs that regulate BK current properties 
 Human KCNMA1 SNPs predicted to affect BK current properties were chosen 
from a table of known SNPs constructed by Jessica Lu.  SNPs chosen for experiments 
were evaluated based upon: 1) proximity of SNP to residues previously identified to 
regulate BK current properties, 2) the magnitude of change in amino acid properties 
introduced by the SNP, 3) association of the SNP to disease, and 4) the predicted effect of 
the SNP on protein function using the software algorithms MutPred and NetPhos. 
 MutPred is a freely-available computational model based on protein sequence that 
models changes in structure and function.  While earlier computational modeling 
programs, such as SIFT (Ng and Henikoff, 2003) and PolyPhen (Ramensky et al., 2002), 
predict deleterious effects of amino acid mutations using sequence homology and 
structural information from protein databases, MutPred is unique because it is trained on 
five databases of known protein mutations and generates a hypothesis for the molecular 
mechanism underlying a deleterious effect on protein function (Li et al., 2009).  To 
evaluate a mutation as deleterious, MutPred assigns the mutation a general score from 0 
(nondeleterious) to 1 (deleterious).  Additionally, MutPred provides a hypothesis, if 
possible, for the mechanism underlying the deleterious effect of mutations on protein 
function.  For this study, we were most interested in mutations with a MutPred general 
score ≥ 0.5 that had actionable hypotheses. 
 As a control to determine the ability of MutPred to identify SNPs that would alter 
BK current properties, we determined the MutPred score for mutations previously 




mutation in the Ca2+ bowl (D959A), the Ca2+ sensing site in RCK1 (D434A), and voltage 
sensor (R272Q).  
 NetPhos was used to predict whether SNPs would affect phosphorylation of 
specific residues in hBK.  NetPhos is an algorithm that predicts phosphorylation by 
comparing a given sequence with hundreds of known phosphorylatable sequences (Blom 
et al., 1999). Our lab used NetPhos to predict phosphorylation of S642, as previously 
described (Shelley et al., 2013).  We used NetPhos on the hBK before and after 
introducing SNPs to hBK to predict whether specific residues might be phosphorylated 
after introduction of SNPs.  To evaluate if a mutation affected residue phosphorylation, 
NetPhos would assign each serine, tyrosine, and threonine a score between 0 (not 
phosphorylated) and 1 (phosphorylated).   SNPs that either introduced or eliminated a 
residue with a NetPhos score of > 0.5 were considered for experiments. 
5.2.3 HEK cell culture and electrophysiology  
 HEK293T cells were cultured and transfected as described in Chapter 3.  For 
symmetrical K+ experiments, macroscopic BK currents were recorded in an inside-out 
patch configuration from HEK293T cells transfected with the construct of interest. 
Recordings were acquired at 50 kHz.  Thin-walled glass capillaries with resistances, after 
fire-polishing, between 1.5 and 3 MΩ were used for experiments.  The internal (bath) 
solution contained (in mM): 140 KMeSO3, 2 KCl, and 20 HEPES, while the external 
(pipette) solution contained: 140 KMeSO3, 2 KCl, 1 MgCl2, and 20 HEPES.  The 
solutions were set to a pH of 7.2 using KOH, as setting the pH of intracellular solutions 
with NaOH was found to cause voltage-dependent block in the outward currents above 




Ca2+ concentration were calculated using WebMaxC as described in Chapter 3.  Solutions 
were buffered with either EGTA (0 µM Ca2+) or HEDTA (1 and 10 µM Ca2+).  For 
calculations with WebMaxC, the temperature was 20 °C and the ionic value was 0.16.  
 In symmetrical K+, BK currents were evoked from a holding potential of -100 
mV, using 20 ms voltage steps from -150 mV to 300 mV, followed by a 10 ms 
hyperpolarizing step back to -80 mV to generate tail currents.  G-V analysis was 
conducted at 200 µs after the peak tail current as previously described (Brenner et al., 
2000a), to minimize contamination by the capacitive transient.  Activation kinetics were 
determined by fitting the rising phase of the outward currents to single exponential 
functions.  To measure deactivation kinetics, patches were subjected to a 20 ms voltage 
step to +200 mV, followed by 10 ms voltage steps from -200 mV to -50 mV.  
Deactivation kinetics were measured by fitting tail currents with single exponential 
functions.  Leak currents were subtracted using a P/5 protocol with a subsweep holding 
potential of -120 mV as previously described (Shelley et al., 2013). 
 In physiological K+, macroscopic BK currents were elicited in an inside-out patch 
configuration.  The external (pipette) solution contained (in mM): 134 NaCl, 6 KCl, 1 
MgCl2, 10 glucose, and 10 HEPES.  The pH was adjusted to 7.4 with NaOH.  The 
internal (bath) solution contained: 110 K-aspartate, 10 NaCl, 30 KCl, 10 HEPES, 1 
MgCl2, 5 HEDTA and 10 µM free-Ca2+.  The pH was adjusted to 7.2 with KOH.  To 
generate the G-V relationship, currents were evoked by holding patches at -100mV, 
followed by 20 ms square voltage steps from -150 mV to +150 mV, followed by a 10 ms 




G-V relationships were generated for all patches subjected to action potential voltage 
commands.   
 Following square waveform current recordings, we recorded BK currents in 
response to action potential waveforms.  The peak current elicited by each action 
potential voltage command was normalized to the peak steady state current evoked by 
square waveforms when determining the G-V relationship.  The peak steady-state current 
for each patch occurred between +90 and +120 mV.  Four action potential commands 
were used for experiments; two representative action potentials from a mouse 
suprachiasmatic nucleus (SCN) neuron during the circadian day (SCNDay) or night 
(SCNNight) (Shelley et al., 2013), representative action potentials from a mouse SANC 
(Lai et al., 2014), and a representative action potential evoked from a mouse urinary 
bladder smooth muscle cell.  SCN action potentials were obtained from whole-cell 
recordings from mouse SCN neurons.  Mouse SANC action potentials were obtained 
from mouse SANCs in a perforated patch configuration (Lai et al., 2014). Mouse bladder 
action potential waveforms were extracted using Dagra (Blue Leaf Software, Hamilton, 
New Zealand) from an image obtained from Dr. Tom Heppner at the University of 
Vermont.  The voltage command waveform used for each experiment can be found in 
Figure 27. 
5.2.4 Statistics and Data Analysis 
 Data analysis was performed using pClamp 10 (Axon Instruments).  Graphs were 
generated in Prism 5.0 (GraphPad), and statistical analysis was performed using Origin 
Lab 8.5 (Origin Lab).  Prism 5.0 was used for two-way repeated-measure ANOVAs when 





5.3.1 Characterization of mouse and human BK constructs 
 To determine whether the eight amino acids introduced to humanize mBKQEERL 
altered BK currents (Table 3), we characterized macroscopic current recordings from 
both hBK and mBKQEERL.  hBK and mBKQEERL have identical exons and residue 
combinations (Table 2).  hBK and mBKQEERL had similar V1/2 values, activation, and 
deactivation kinetics except when noted (Figure 18, Figure 19, Table 4), suggesting that 







Figure 18: Characterization of mBKQEERL and hBK currents  
(A) Representative macroscopic BK currents recorded at indicated Ca2+ concentration 
from inside-out patches in response to depolarizing voltage steps.  Currents were 
recorded from separate patches.  (B) Normalized conductance-voltage (G-V) relationship 
for BK currents at indicated Ca2+ concentrations.  V1/2 values for each variant at indicated 


























Figure 19: Activation and deactivation kinetics for mBKQEERL and hBK  
(A) Activation time constants were determined by fitting the rising phase of the outward 
currents to single exponential functions.  Constructs had significantly different activation 
kinetics at 100 µM Ca2+ (P = 0.002).  (B) Deactivation time constants were determined 
by fitting tail currents to single exponential functions, following voltage steps to +200 
mV.  Constructs had significantly different deactivation kinetics at 10 µM Ca2+ (P = 












100 µM Ca2+ 10 µM Ca2+ 1 µM Ca2+ 0 µM Ca2+ 
mBKQEERL -4 ± 4 (11)  49 ± 3 (10)  165 ± 5 (11) 193 ± 7 (15) 
hBK 
-14 ± 1 (18) * 
P = 0.01 
53 ± 2 (28) 
152 ± 3 (14) * 
P = 0.04 
203 ± 7 (10) 
 
 
Table 4: V1/2 values for mBKQEERL and hBK currents 
Number of patches used for analysis is listed in parentheses. Significance (*, P < 0.05) 






















5.3.2 Identification of four SNPs that regulate BK current properties 
 From a comprehensive table of known human KCNMA1 SNPs (assembled by 
Jessica Lu), we predicted four SNPs that could potentially alter BK current properties.  
For this study we limited the SNPs chosen to ones that were linked with disease or in the 
gating ring (C-terminus) of the BK α-subunit, since the gating ring regulates of Ca2+-
dependent activation (Jiang et al., 2002; Xia et al., 2002; Yusifov et al., 2008; Zhang et 
al., 2010).  We performed an extensive literature search to identify non-synonymous 
SNPs in functional domains of the C-terminus that regulate BK current properties, and to 
identify SNPs throughout the α-subunit implicated in pathophysiological conditions.  
Furthermore, we utilized MutPred and NetPhos to predict SNPs that would have a 
deleterious effect on protein function, or alter phosphorylation.  Through this search, we 
identified four SNPs (A138V, C495G, N599D, and R800W) for further study (Figure 
20). 
 A138V was chosen based on previous data identifying this SNP in a data set of 
117 autistic patients (Laumonnier et al., 2006).  In this study, whole-cell BK currents 
were isolated from lymphoblastoid cell lines isolated from one autistic patient and control 
patients, and it was found that BK currents from the autistic patient cell line were 
approximately 70% smaller than those of the control cells.  Additionally, the resting 
membrane potential was significantly more depolarized (4.8 mV)(Laumonnier et al., 
2006).  These results suggest that A138V reduces current amplitude and may alter 
excitability, although the mechanism is unclear.  The A138V mutation SNP had a 
MutPred score of 0.310, suggesting that there is a low probability that A138V has a 




some BK control mutations; for example, the mD959A mutation in the Ca2+ bowl causes 
a + 80 mV shift in  the voltage at half of the maximum conductance as derived from the 
G-V Boltzmann fit (V1/2) (Bao, 2004), even though the mutation has a low MutPred score 
(0.343). 
 C495G was chosen for experiments based on relevance of this residue in previous 
work (Zhang and Horrigan, 2005; Zhang et al., 2006), its position in a conserved linker 
region in RCK1 known to regulate the G-V relationship (Zhang and Horrigan, 2005), and 
because glycine residues convey flexibility to protein structures.  In previous studies, 
C495A (mBKC430A) inhibited the effect of cysteine-modifying reagents, which normally 
cause a negative-shift in the G-V relationship (Zhang and Horrigan, 2005).  Additionally, 
mBKC430A currents exhibited right-shifted V1/2 values at low (≤1 µM) Ca2+ compared to 
WT channels (Zhang and Horrigan, 2005).  In the context of hBK used in this study, 
MutPred predicted that C495G would have a deleterious effect on protein function 
(0.568), and the actionable hypothesis for C495G was a gain of disorder. 
 The third SNP chosen for this study was N599D.  N599D was chosen because the 
SNP introduces a negatively-charged aspartic acid directly adjacent to E600 (mBKE535), a 
residue critical to the Ca2+ sensing site in RCK1 (Zhang et al., 2010).  mBKE535, along 
with mBKD362/D367, are essential to the RCK1 Ca2+ sensing site.  mBKE535A caused a 
+100mV shift in the Δ V1/2 , where Δ V1/2 = V1/2 (0 uM Ca2+) – V1/2 (100 uM Ca2+), 
compared to the +200 mV shift in Δ V1/2 for WT channels.  This indicates mBKE535A 
reduces the Ca2+ sensitivity of BK channels, and that mBKE535 is essential for activation 
of BK channels by Ca2+.  Additionally, N599D was chosen because of its MutPred score 




Because N599D (asparagine to aspartic acid) mutation is a non-conservative mutation 
that introduces a negatively-charged residue into the RCK1 Ca2+ sensing site, we 
hypothesized that N599D may alter the structure of the RCK1 Ca2+-sensing site, which 
would affect Ca2+ sensing and subsequently alter the G-V relationship and kinetics of BK 
currents. 
 R800W, located within RCK2, was the fourth SNP chosen for experiments.  
R800W was chosen due to its vicinity to G798 and N801, two residues implicated in 
regulating the interface between RCK1 and RCK2 (Kim et al., 2008).  Also, R800W is a 
non-conservative amino acid substitution, as the mutation increases the size of the residue 
and eliminates a positive charge.  Furthermore, the R800W received a MutPred score of 
0.706, with an actionable hypothesis for being a loss of methylation at R800.  
 G798 and N801 (G803 and N806 in the rat BK (rBK) sequence) are two residues 
thought to regulate the flexible interface that governs interaction between RCK1 and 
RCK2 (Kim et al., 2008).  rBKG803D caused a hyperpolarizing shift in the G-V 
relationship at multiple Ca2+ concentrations, while N806K caused a +45 mV 
hyperpolarizing shift.  Furthermore, mutating rBKG803 to other residues introduced either 
hyperpolarizing (P, D, E, C, A), depolarizing (K), or no change to the V1/2.  Because this 
data was performed on rBK, which contains a residue sequence at splice site 3, it is 
unknown whether G798 mutations would alter the structure and function of the hBK 
variant, which lacks the S3 exon.  However, assuming that G798D alters hBK and rBK 
current properties through similar mechanisms, and because of R800W introduces a 
large, bulky tryptophan residue to the interface, we predict that R800W may alter the 
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Table 5: Summary of the properties of SNPs chosen for experiments  
hBK SNPs chosen for experiments are listed, along with their location in the channel 
structure.  The rationale for each SNP, including previous work at or near the residues of 
interest, the nature of the amino acid substitution, and MutPred score are also listed.  
Mutations previously determined to affect BK current properties were used as controls to 



















Figure 20: Location of KCNMA1 SNPs used in this study 









5.3.3 C495G, N599D, and R800W regulate steady state current properties 
 To investigate the effect of SNPs on steady-state BK current properties, we first 
expressed SNP-containing BK channels in HEK293T cells and recorded macroscopic BK 
currents in an inside-out patch configuration in symmetrical K+ at 0, 1, 10, and 100 µM 
intracellular Ca2+ (Figure 21).  The effects of SNPs on BK current G-V relationships, 
activation, and deactivation kinetics varied depending on the Ca2+ concentration used for 
recordings.  At 100 µM Ca2+, the G-V relationship for A138V, C495G, N599D, and 
R800W were all significantly right-shifted compared to hBK (Figure 22) as the V1/2 for 
hBK was 11 to 18 mV more depolarized than the V1/2 for each SNP (Table 6). 
Accompanying the right-shift in G-V relationship, we found that A138V, C495G, N599D 
and R800W currents all also exhibited slower time constants of activation (τAct, Figure 
23) and faster time constants of deactivation (τDeact, Figure 24). 
 At 10 µM Ca2+, the G-V relationship of C495G currents was significantly left-
shifted compared to hBK, suggesting that C495G enables BK channels to open more 
easily at 10 µM Ca2+ (Figure 22B).  Correlating with the depolarized G-V relationship, 
C495G currents also exhibited slightly faster τAct (Figure 23B) and slower τDeact (Figure 
24B), than hBK currents. Interestingly at 10 µM Ca2+, R800W currents had V1/2 values 
that were significantly more positive compared to hBK, and R800W currents exhibited 
slower τAct (Figure 23D) and faster τDeact (Figure 24D).  This suggests that R800W 
channels open less-easily compared to hBK at 10 µM Ca2+.  Unlike C495G and R800W, 
which demonstrated different V1/2 and kinetic properties at 10 µM Ca2+, the V1/2 values 
for A138V and N599D were not significantly different from hBK at 10 µM Ca2+ (Table 




Figure 24), further suggesting that these mutant constructs behaved similarly to hBK at 
10 µM Ca2+.  
 At 1 µM Ca2+, the effects of SNPs on steady-state current properties were 
complex.  The leftward shift in G-V and faster activation kinetics compared to hBK 
exhibited by C495G at 10 µM Ca2+ was also observed at 1 µM Ca2+, as C495G currents 
demonstrated an 8 mV, albeit not statistically significant, hyperpolarizing shift in the V1/2 
compared to hBK (Table 6), as well as faster τAct (Figure 23B).  The G-V relationship of 
R800W currents, similar to what occurred at 100 and 10 µM Ca2+, was approximately 20 
mV right-shifted compared to hBK (Figure 22D).  The right-shift in G-V relationship was 
accompanied by slower τAct and faster τDeact (Figure 23D, Figure 24D).  This suggests that 
R800W causes BK channels to open less easily in 1 µM Ca2+.  Interestingly, N599D 
currents, which did not cause a significant shift in V1/2 at 10 µM Ca2+, induced a 20mV 
depolarizing shift in V1/2 compared to hBK (Figure 22C, Table 6) and N599D currents 
exhibited slower τAct (Figure 23C), suggesting that the N599D mutation causes BK 
channels to open less easily at low Ca2+ concentrations compared to the hBK.  The G-V 
relationship, activation and deactivation time constants for A138V currents at 1 µM Ca2+ 
were not significantly different from hBK (Figure 22A, Figure 23A, Figure 24A). 
 Lastly at 0 µM Ca2+, we found no significant differences in the G-V relationship, 
activation and deactivation time constants between hBK and A138V, C495G, and N599D 
currents (Figure 22, Figure 23, Figure 24).  Although the G-V relationship and τDeact at 0 
µM Ca2+ were not different between R800W and hBK (Figure 22D, Figure 24D, Table 
6), surprisingly we found that R800W currents still demonstrated slower τAct (Figure 




presence of low (1 µM), intermediate (10 µM), or saturating (100 µM) Ca2+ rather than 
under Ca2+-free conditions, this data suggests that the SNPs we investigated primarily 







Figure 21: hBK and hBK SNP currents in symmetrical K+ 
Representative macroscopic BK current traces recorded at the indicated Ca2+ 
concentration from inside-out patches from hBK and hBK SNPs.  Currents were recorded 













Figure 22: G-V relationship of hBK SNP currents in symmetrical K+ 
(A-D) G-V relationships between hBK and A138V, C495G, N599D, and R800W 
currents.  hBK is denoted by open symbols and hBK SNPs are denoted by shaded 
symbols at 100 (circles), 10 (squares), 1 (diamonds), 0 µM (triangles) Ca2+.  (E) Plot of 
V1/2 versus Ca2+ exemplifying differences in the voltage-dependence of activation 
between hBK and BK channel SNPs at each Ca2+ concentration.  Significance (*, P < 
0.05) was tested within each Ca2+ concentration using a one-way ANOVA.  V1/2, P 







100 µM Ca2+ 10 µM Ca2+ 1 µM Ca2+ 0 µM Ca2+ 
hBK -14 ± 1 (18) 53 ± 2 (28) 152 ± 3 (14) 203 ± 7 (10) 
A138V 
0 ± 3 (9) * 
P = 0.001 
51 ± 3 (8) 153 ± 5 (9) 200 ± 8 (8) 
C495G 
-3 ± 1 (15) * 
P = 0.009 
39 ± 3 (10) * 
P = 0.019 
144 ± 5 (10) 198 ± 7 (10) 
N599D 
0 ± 2 (15) * 
P = 1 x 10-4 
54 ± 4 (12) 
172 ± 4 (11) * 
P = 0.029 
212 ± 8 (11) 
R800W 
3 ± 2 (19) * 
P = 1 x 10-6 
71 ± 3 (16) * 
P = 2 x 10-4 
172 ± 5 (10) * 
P = 0.035 
210 ± 7 (11) 
 
Table 6: V1/2 values for hBK and hBK SNP currents   
Number of patches used to acquire data at each Ca2+ concentration is denoted in 
parenthesis.  Significance (*, P < 0.05) was tested using a one-way ANOVA within each 

























Figure 23: Activation kinetics for hBK SNPs in symmetrical K+ 
Activation kinetics were determined by fitting the rising phase of hBK (open symbol) and 
hBK SNP (closed symbols) currents to single exponential functions at 0 (diamond), 1 
(triangle), 10 (square), and 100 (circle) µM Ca2+.  Significant differences in activation 
kinetics were found at 100 µM (A138V, P < 0.001; C495G, P < 0.001; N599D, P = 
0.001; R800W, P < 0.001), 10 µM (C495G, P = 0.002; R800W, P < 0.001), 1 µM 
(C495G, P = 0.032; N599D, P < 0.001; R800W, P = 0.001), and 0 µM Ca2+ (R800W, P = 

























Figure 24: Deactivation kinetics for hBK SNPs in symmetrical K+ 
Deactivation kinetics were determined by fitting tail currents of hBK (open symbol) and 
hBK SNP (closed symbols) currents to single exponential functions at 0 (diamond), 1 
(triangle), 10 (square), and 100 (circle) µM Ca2+.  Significant differences in deactivation 
kinetics were found between hBK and hBK SNPs at 100 µM (C495G, P < 0.001; N599D, 
P = 0.016; R800W, P < 0.001), 10 µM (A138V, P = 0.002; C495G, P < 0.001), and 1 µM 










5.3.4 C495G and R800W alter BK current activation kinetics in physiological solutions  
 To determine whether the altered G-V relationships and current kinetics caused 
by BK channel SNPs would still occur under physiological conditions, we next recorded 
macroscopic BK currents in a physiological K+ gradient.  We recorded currents in 
physiological concentrations of Na+ (10 mM internal/134 mM external) and K+ (140 mM 
internal/6 mM external)(Herrera et al., 2002).  Although an extensive amount of work has 
examined the effect of C-terminal mutations on BK current properties (Kim et al., 2008; 
Yang et al., 2010; Zhang and Horrigan, 2005; Zhang et al., 2010), few studies examine 
the properties of BK currents evoked in physiological K+.  Because C495G and R800W 
currents exhibited altered G-V relationships and current kinetics in symmetrical K+, we 
hypothesized that C495G and R800W would also affect these BK current properties in 
physiological K+.  
 To test the hypothesis that C495G and R800W regulate BK current properties in 
physiological K+, we first recorded macroscopic BK currents evoked by square voltage 
steps in an inside-out patch configuration.  These experiments were performed with 10 
µM intracellular Ca2+, as 10 µM Ca2+ is a physiologically-relevant Ca2+ concentration 
that activates BK currents at both Ca2+ spark sites and in CaV channel/BK channel 
nanodomain complexes (Berkefeld et al., 2006; Fakler and Adelman, 2008; Perez et al., 
2001).  Additionally, we chose 10 µM Ca2+ because C495G and R800W altered the G-V 
and current kinetics at 10 µM Ca2+ in symmetrical K+ solutions.  Interestingly, although 
we observed left and right-shifts in the G-V relationship with C495G and R800W, 
respectively in symmetrical K+ (Figure 22, Table 6), we did not observe significant shifts 




C495G currents still had faster τAct, and R800W currents had slower τAct compared to 
hBK currents (Figure 25C), which mimicked the trend observed in symmetrical K+ 
solutions.  Deactivation kinetics between hBK, C495G, and R800W currents were not 
significantly different (Figure 25D).  Similar to our results in symmetrical K+, A138V 
and N599D currents exhibited similar G-V relationships and τAct compared to hBK 

























Figure 25: Characterization of hBK SNPs in physiological K+ 
 (A) Representative macroscopic current traces from hBK and hBK SNPs at 10 µM 
intracellular Ca2+.  (B) G-V relationship between hBK and hBK SNPs.  (C) Activation 
time constants for hBK SNP currents. Time constants were determined by fitting the 
rising phase of the currents to single exponential functions. (D) Deactivation time 
constants for hBK, C495G, and R800W currents. Time constants were determined by 
fitting tail currents to single exponential functions.  Significant differences in activation 
kinetics were found between hBK and C495G (P = 0.004) and R800W (P < 0.001).  
Statistical significance with activation/deactivation kinetics was tested using a two-way 
repeated measures ANOVA with Bonferroni post-hoc test.  n = 9 – 18 patches analyzed 




5.3.5 C495G and R800W regulate BK currents evoked by action potentials 
 To test the hypothesis that KCNMA1 SNPs alter BK currents evoked under 
physiological conditions, we measured peak BK current amplitudes evoked by action 
potential waveforms obtained from mouse SCN neurons, mouse urinary bladder cells, 
and mouse SANCs.  These cell types were chosen because BK currents regulate the 
excitability of each of these cells, and these action potentials exhibit a range of driving 
forces and depolarization rates (Heppner et al., 1997; Lai et al., 2014; Shelley et al., 
2013).  Because the G-V relationships and deactivation kinetics for each SNP were 
similar in physiological K+, we predicted that the currents amplitudes elicited by C495G 
and R800W channels may differ compared to hBK currents due to altered activation 
kinetics.   
 We predicted that SNP-induced changes in activation kinetics would alter the 
action potential-evoked current amplitude because of the depolarization rate of the 
utilized action potentials.  The peak current is a function of the current activation kinetics, 
since currents with slower τAct require more time to reach a maximally “activated” state 
than currents with faster τAct.  Therefore, action potentials with longer depolarization 
rates, such as the SANC action potential, will enable BK currents more time to reach a 
maximally activated state than action potentials with shorter depolarization rates, such as 
the SCN neuron action potentials (Figure 26A).  Example action potential evoked 
currents from each action potential stimulus is provided in Figure 26B. 
After recording macroscopic currents in response to square voltage steps from 
each patch, the patch was subjected to the four action potential waveforms to evoke BK 




action potential-evoked current was normalized to the maximum outward current evoked 
from each patch using the square voltage step protocol.  When comparing the peak 
normalized current evoked by SCNDay action potentials, we found that C495G currents 
were significantly larger than hBK currents, while R800W currents were significantly 
reduced compared to hBK currents (Figure 27A). The amplitudes of A138V and N599D 
currents evoked by SCNDay were not significantly different than hBK currents (Figure 
27A).  When utilizing the SCNNight action potential, which has a more depolarized resting 
membrane potential, slower upstroke velocity, longer half-width, and less depolarized 
peak potential compared to SCNDay (Figure 27B), we found that C495G currents trended 
towards having larger currents, while R800W normalized currents were significantly 
smaller compared to hBK currents (Figure 27B).  The amplitudes of the currents evoked 
by SCNDay and SCNNight correlate well with the activation kinetics observed with C495G 
and R800W patches in physiological K+, since C495G currents had more rapid τAct and 
R800W currents had slower τAct (Figure 25C).  As expected based on the symmetrical K+ 
data at 10 µM Ca2+ (Figure 22-24), and the lack of difference in G-V relationship, or 
activation kinetics in physiological K+ (Figure 25), A138V and N599D did not exhibit 
significantly altered normalized peak-current amplitudes with either the SCNDay or 
SCNNight action potentials (Figure 27A, Figure 27B).   
 Next, we examined BK currents evoked by bladder smooth muscle cell and 
mouse SANC action potential waveforms.  Utilizing the bladder smooth muscle action 
potential, C495G currents trended towards being larger than hBK currents and R800W 
currents trended towards being smaller than hBK currents (Figure 27C). A138V and 




analyzing currents evoked by SANC action potentials, which had the longest duration 
and largest peak amplitude of the action potentials used for experiments, we found that 
R800W normalized currents were significantly reduced compared to hBK currents 
(Figure 27D).  A138V, C495G, N599D did not significantly affect the peak current 
evoked by a SANC action potential (Figure 27D).  Interestingly, the difference in peak 
current amplitudes between C495G and R800W with hBK was less when evoking 
currents with the SANC action potentials and bladder action potentials, which were 
appreciably longer, than with SCNDay or SCNNight action potentials.  This data suggests 
that BK current activation kinetics play an essential role in determining the peak 
amplitude of BK currents evoked by a physiological stimulus in physiological K+, and 
that this trend becomes less apparent with longer depolarizing stimuli that allow BK 






















Figure 26: Action potential waveforms used for recordings and corresponding 
evoked currents  
(A) Schematic of representative action potential waveforms (A) and corresponding 
evoked BK currents (B).  Evoked currents were recorded from a single patch expressing 










































Figure 27: Normalized BK current amplitudes evoked by action potentials 
Action potential voltage commands and corresponding normalized current amplitudes 
evoked by SCNDay (A), SCNNight (B), bladder cell (C), and SANC (D) action potentials.  
The current amplitudes evoked by the SAN action potential (D) were measured from the 
current evoked by the second action potential.  Asterisks denote significance where P < 
0.05.  Significance was tested using a one-way ANOVA.  Number of patches per 





Table 7: Normalized current amplitudes in response to action potential waveforms   
Normalized current amplitudes of BK currents evoked by action potential waveforms.  
Numbers in parenthesis indicate the number of patches analyzed per condition.  Asterisks 
denote statistical significance (P < 0.05) from hBK using a one-way ANOVA.   
Construct 
Normalized Current Amplitude 
SCNDay SCNNight Bladder SAN 
hBK 0.031 ± 0.003 (18) 
0.019 ± 
0.002 (18) 
0.127 ± 0.016 
(11) 
0.262 ± 0.018 
(18) 
A138V 0.034 ± 0.006 (10) 
0.020 ± 
0.003 (10) 
0.124 ± 0.009 
(6) 




0.005 (17) * 
P = 0.049 
0.029 ± 
0.003 (17) 
0.172 ± 0.025 
(9) 
0.298 ± 0.017 
(17) 
N599D 0.038 ± 0.005 (8) 
0.022 ± 
0.003 (8) 
0.169 ± 0.018 
(5) 




0.006 (17) * 




P = 0.017 
0.087 ± 0.012 
(9) 
0.175 ± 0.015 
(17) * 




Figure 28: Paired normalized current amplitudes evoked by BK channels in 
response to SCN action potentials 
Because three out of 17 R800W patches did not evoke current in response to SCNNight 
action potentials, we verified that all patches evoked current in response to SCNDay action 
potentials.  Normalized currents evoked by SCNNight action potentials were always lower 
than currents evoked by SCNDay action potentials, suggesting that differences in current 
properties, and differences in the amplitude of the action potential are essential in 






 BK current properties are determined by multiple factors, such as phosphorylation 
(Yan et al., 2008), alternative splicing (Johnson et al., 2011; Shelley et al., 2013; Xie and 
McCobb, 1998), and auxiliary subunits (Brenner et al., 2000a; 2005; Yan and Aldrich, 
2010), but few studies have addressed KCNMA1 SNPs or the effect of SNPs on BK 
current properties (Du et al., 2005; Jiao et al., 2011; Klassen et al., 2011; Laumonnier et 
al., 2006).  In this study, we identified that SNPs can modulate BK current properties, and 
that SNP-induced changes in BK current properties may affect the amplitude of BK 
currents evoked by action potentials.  This data suggests that SNPs in KCNMA1 are an 
under-investigated mechanism of BK current diversity. 
5.4.1 SNPs alter BK current properties in symmetrical K+ 
 A138V, which is linked with autism, is one of the few BK SNPs that has been 
linked with disease (Laumonnier et al., 2006).  Although we hypothesized that autism 
may be linked with differences in BK current properties, interestingly we found that BK 
current properties were not affected by A138V in symmetrical K+.  In the previous report, 
BK currents recorded from a cell line obtained from an autistic patient with the A138V 
SNP were smaller than BK currents from control patient cells.  Interestingly, we found 
that A138V expression was lower visually compared to hBK and other hBK SNPs 
(Figure 29), and although current properties were not greatly affected, the magnitude of 
currents evoked by A138V channels trended lower than the amplitudes of hBK currents 
(data not shown).  Previous analysis of this sequence suggests that this substitution 
creates a splice donor site in the second exon, which could potentially affect A138V 




suggests that the lower current density in A138V patient cells may be due to differences 
in channel expression and trafficking, rather than changes in current properties. 
 C495G induced different effects on the G-V relationship compared to other 
studies that examined the effect of mutations at C495.  C495 (mBKC430) is within a series 
of 8 amino acids in RCK1 that links an α-helix and β-sheet, and this linker is conserved 
among BK channels but not other K+ channels (Zhang and Horrigan, 2005).  Because 
deletion of the linker causes a left-shift in the G-V relationship, it suggests that 
modifications of mBKC430 disrupt the linker or the linker’s interactions with other 
residues in the gating ring (Zhang and Horrigan, 2005).  Interestingly, BK currents 
evoked from C495G-containing channels at 1 and 10 µM exhibited “gain-of-function” 
properties, as the G-V relationship was shifted to more hyperpolarized potentials (Figure 
22), and C495G currents exhibited faster τAct compared to hBK currents (Figure 23B). 
Based on the previous studies and our findings, our results suggest that the C495G SNP 
may influence the structure the αD-βD linker in RCK1 and its interaction with 
surrounding residues.  Potentially, the glycine residue causes the αD-βD linker to 
become more flexible and alters the structure of the gating ring in the presence of Ca2+.  
Further studies, such as recording currents when C495 is mutated to residues that convey 
less flexibility, would be required to test this hypothesis. 
























Figure 29: Expression of hBK and hBK SNPs in HEK293T cells   
Representative images acquired of HEK293T cells expressing hBK channel constructs.  
Transfections were performed using TransIt LT-1 transfection reagent.  Images were 




 The effects of N599D on BK current properties were also complex.  Previous 
mutations of N599 (mBKN534A) cause a relatively small effect on the G-V relationship 
compared to mutations at E600 (mBKE535A), a residue critical in RCK1 Ca2+ sensing 
(Zhang et al., 2010).  We hypothesized that N599D may alter the structure of the RCK1 
Ca2+ sensing site in the presence of Ca2+, since the SNP introduces a negatively charged 
residue directly next to E600.  Based on our data in low intracellular Ca2+ (1 µM Ca2+), 
the negative charge introduced by N599D may disrupt the interaction of the RCK1 Ca2+ 
sensing site with other residues within the gating ring, and therefore alter the G-V 
relationship and activation kinetics.  It is unknown how N599D would affect the way 
Ca2+ ions interact with the high-affinity Ca2+ sensing site in RCK1, since crystal 
structures of the gating ring lack Ca2+ ions at the RCK1 Ca2+ sensing site (Yuan et al., 
2011).  Therefore, further studies would be required to understand the structural 
mechanism that enables N599D to regulate BK current properties in low Ca2+ conditions.  
 R800W caused the most consistent effect on BK current properties, as R800W 
currents generally exhibited loss-of-function properties.  R800W is located near a 
proposed flexible interface between RCK1 and RCK2, and mutations of residues in the 
vicinity of R800W in the rat BK channel (rBKG803D) cause a negative shift in the G-V 
relationship, and an increase in the single channel PO (Kim et al., 2008). Because R800 
itself was not mutated in this study and is not the focus of any previous crystal structure 
studies, the role of R800 in regulating the G-V or the rate at which the pore opens is 
unclear.  It can be hypothesized that elimination of the positive charge and addition of a 
large, bulky tryptophan residue may disrupt the RCK1/RCK2 interface, therefore 




 We did not observe any change in G-V relationship with any of the SNPs we 
analyzed at 0 µM Ca2+ (Figure 22, Table 6). Because previous studies that delete or 
mutate residues directly involved in Ca2+ coordination do not have a significant effect on 
the G-V relationship or V1/2 values in 0 µM Ca2+ conditions (Xia et al., 2002; Zhang et 
al., 2010), it was not surprising that we did not find significant differences in the G-V or 
V1/2 values between hBK and hBK-SNP channels.  Similar to what occurred in the 
presence of Ca2+, R800W caused an increase in the τAct at 0 µM Ca2+ (Figure 23), 
indicating that R800W currents activate slower compared to hBK currents under Ca2+-
free conditions.  Further studies, especially ones that examine the crystal structure around 
this residue, would be necessary in order to understand the mechanism underlying 
R800W’s effects on current activation kinetics under nominal Ca2+ conditions.  
5.4.2 SNPs alter BK current activation kinetics in physiological K+ solutions 
 Unexpectedly, the effects of SNPs on current properties were different in 
symmetrical and physiological K+ solutions.  We found that the shifts in G-V relationship 
observed in symmetrical K+ due to BK SNPs were not present in physiological K+, but 
the changes in activation kinetics were maintained (Figure 25C).  It is unknown how 
physiological solutions would affect the structure of the C-terminus or Ca2+-dependent 
activation of BK currents.  However, differing results in G-V relationships in 
symmetrical and physiological K+ solutions have been previously reported (Jaffe et al., 
2011; Wang et al., 2009; 2014).  It could be speculated that the ionic environment created 
by physiological solutions alters the coupling between the voltage-sensor, pore, and 
gating ring.  We did observe block of BK currents by Na+ in physiological solutions at 




precluded any affects on the G-V.  Further experiments, would be required to understand 
the mechanism underlying why SNPs have differing effects on G-V relationships in 
symmetrical and physiological K+ solutions.  Additionally, further experiments could be 
performed at different intracellular Ca2+ concentrations to identify if shifts in the G-V 
relationship occur in physiological solutions at different Ca2+ concentrations. 
5.4.3 BK channel SNPs alter the amplitude of currents evoked by physiological stimuli 
 Despite SNPs not affecting BK current G-V relationships in physiological K+, the 
current amplitudes evoked by action potential waveforms did exhibit differences.  Our 
data suggests that a potential mechanism underlying the altered action potential-induced 
peak current amplitudes is changes in current activation kinetics.  Shorter action 
potentials such as the SCNDay action potential enhanced the effect of differences in 
activation kinetics on BK current amplitudes.  For example, faster activating currents 
evoked by C495G-channels were 54% larger than hBK, whereas slower-activating 
currents evoked by R800W-channels were 51% smaller than hBK currents.  However, as 
the action potential depolarization phase became longer, the magnitude of difference 
between hBK and hBK-SNP currents was reduced, presumably because the longer 
depolarization phases enabled increased current recruitment and reduced the influence of 
activation kinetics.  This was evident when comparing current amplitudes evoked by the 
SAN action potential, as C495G-currents were only 13% larger than hBK currents, while 
R800W-currents were only 33% smaller than hBK (Figure 27D). 
 The differences in BK current properties induced by SNPs may also have 
important physiological implications, as BK currents regulate excitability in multiple 




and sinoatrial node (Lai et al., 2014).  Because the difference in BK current amplitude 
caused by SNPs is more apparent with shorter action potentials, it could be expected that 
the effects of BK channel SNPs on cellular excitability may vary depending on the cell 
type.  Furthermore, because SNPs in KCNMA1 induced a range of differences in current 
properties, this data suggests that SNPs may be another mechanism of introducing BK 
current diversity in physiological conditions. 
5.5 Future Studies 
 Our data provides evidence that non-synonymous SNPs can affect BK current 
properties.  However, we only characterized four of the 99 identified non-synonymous 
polymorphisms, meaning that there may be several more polymorphisms that affect BK 
current properties.  BK channels are extensively alternatively spliced and its been shown 
by our lab and others (Johnson et al., 2011; Shelley et al., 2013; Xie and McCobb, 1998) 
that the exon combination in the C-terminus can alter the current properties, or preclude 
the effects of exons on current kinetics.  Therefore, there are a seemingly infinite number 
of SNP/splice variant channels to record current properties from, and it would be 
interesting to determine whether the mutations we characterized would have identical 
effects on current properties on a different splice variant background. 
 Additionally, our action potential waveform command experiments were 
performed at a single Ca2+ concentration (10 µM).  Physiologically, the Ca2+ sources that 
activate BK currents, which include voltage-gated Ca2+ channels (Berkefeld et al., 2006; 
Herrera and Nelson, 2002) and ryanodine receptors (Brenner et al., 2000b; Nelson et al., 
1995; Sausbier et al., 2005) are dynamically activated by changes in membrane potential 




experiments were performed at a single Ca2+ concentration (10 µM Ca2+), a feasible Ca2+ 
concentration near a Ca2+ spark site or in a Ca2+ channel nano-domain complex with BK 
channels (Berkefeld et al., 2006; Fakler and Adelman, 2008; Perez et al., 2001).  It would 
be interesting to record action potential-evoked currents from KCNMA1 SNPs at a range 
of Ca2+ concentrations in order to determine whether the SNPs we used for experiments 
affect BK current properties at Ca2+ concentrations other than 10 µM Ca2+ in 
physiological solutions. 
 Furthermore, under physiological conditions, the α-subunit of the channel is co-
expressed with auxiliary subunits, such as β1 in smooth muscle (Brenner et al., 2000b; 
McCobb et al., 1995), β4 subunit in neuronal tissue (Brenner et al., 2000a; Meera et al., 
2000), or γ1 subunits in the salivary glands and prostate (Yan and Aldrich, 2012).  These 
subunits affect multiple properties of BK currents, including their voltage-dependence of 
activation, Ca2+-sensitivity, activation and deactivation kinetics, and sensitivity to toxins 
(Brenner et al., 2000a; 2005; McCobb et al., 1995; Meera et al., 2000; Yan and Aldrich, 
2010).  It has previously been demonstrated that β4 subunits have opposite effects on 
current G-V relationships in physiological K+ gradient compared to symmetrical K+ 
(Wang et al., 2014), and similarly, we found shifts in G-V relationship induced by C495G 
and R800W in symmetrical K+ were not observed in physiological K+ solutions.  It would 
be interesting to determine whether these SNPs, which affect the activation and 
deactivation kinetics of BK currents in both symmetrical K+ and physiological solutions, 





 The work performed in this chapter identifies that SNPs in KCNMA1 can 
modulate BK current properties.  The SNPs chosen for this work were either disease-
linked, or in domains of the BK channel C-terminus that regulate Ca2+-dependent 
activation.  We found that the effects of SNPs on BK current properties were Ca2+ 
concentration-dependent.  Also, we found that SNP-induced changes in current properties 
regulate the amplitudes of BK currents evoked by action potential waveforms.  These 
results suggest that KCNMA1 SNPs can increase the diversity of BK currents evoked by 





Chapter 6. Conclusions  
 Although BK channels regulate several different cardiovascular functions, no 
previous studies have indicated that BK channels regulate cardiomyocyte excitability.  
The work presented in the first Specific Aim is the first to identify that BK channels 
regulate the excitability of SANCs, the heart’s predominant pacemaking cells.  We 
identified that abolishment of BK channel function slows heart rate by reducing the firing 
rate of SANCs.  The role that BK currents play in the excitability of SANCs contradicts 
the general role of BK currents play in other smooth muscle cells and neurons, since 
eliminating BK currents generally causes an increase in excitability.  This work not only 
identifies a novel excitatory role for BK currents, but also identifies another channel 
important in the intrinsic excitability of SANCs.   
 Identification of all ion channels that regulate cardiac pacing is essential when 
developing therapies for cardiac arrhythmias.  Mutations of ion channels known to 
regulate the intrinsic excitability of SANCs, such as Na+ and Ca2+ channels can lead to 
sinus node dysfunction (Baig et al., 2010; Lei et al., 2008), and several drugs designed to 
combat arrhythmias work by targeting ion channels (Sanguinetti and Bennett, 2003).  Our 
work contributes to the understanding of the ionic mechanisms that underlie the intrinsic 
excitability of SANCs, which will aid in the development of therapies designed to treat 
cardiac arrhythmias.  Also, this work identifies BK channels as a novel therapeutic target 
for treating sinus rhythm disorders. 
 The second aim of this work identifies that SNPs are an under-investigated 
mechanism that creates BK current diversity in physiological conditions.  SNPs had 




BK currents evoked by action potential waveforms.  The effect of SNPs on BK current 
amplitudes was also dependent on the type of physiological stimulus applied to the 
channels, suggesting that the effect of SNPs on BK currents may vary in different tissues.  
Future work should focus on continuing to characterize other SNPs in KCNMA1.  
Because BK channels are expressed throughout the cardiovascular system, and SNPs can 
affect BK current properties, our work suggests that SNPs in KCNMA1 can greatly 
diversify BK currents in physiological conditions, and could potentially serve as a marker 




Chapter 7. Appendix  
The results of several experiments were not included in the main results sections in 





Figure 30: Detection of BK channel protein via immunoprecipitation 
Example immunoprecipitation blot demonstrating BK channel protein detection in the 
SAN.  Protein was obtained from WT SAN, right atria (RA), two aorta samples (Ao1 and 
Ao2) and Kcnma1−/− (KO) RA. As a control for SAN tissue, the non-specific protein 
samples from the immunoprecipitation were probed for HCN4 expression.  30 µg of 


























Figure 31: Effect of IbTX on the spontaneous contraction rate of mouse SANCs  
(A) Representative contractions from one mouse SAN cell during baseline conditions and 
after application of 230nM IbTX. IbTX is a highly potent, membrane impermeable BK 
channel blocker.  Contractions were measured using optical edge detection software.  (B) 
IbTX causes a reduction in the average contraction rate of SAN cells. p=0.125, 





































Table 8: Heart parameters via echocardiography 
Mouse echocardiogram measurements were performed on wild-type (WT) and transgenic 
mice expressing a gain-of-function BK channel (TgPer1R207Q) before and after transverse 
aortic constriction (TAC).  BK channels regulate vasodilation, and TAC is a well 
established model of pressure-induced hypertrophy of the heart (Rockman et al., 1994).  
We hypothesized that gain of function BK channels would promote vasodilation, and 
therefore prevent cardiac hypertrophy, which was determined by the left ventricular (LV) 
mass.  TAC experiments did not yield the expected increase in LV mass, suggesting that 
the aortic banding was not stringent enough.  Abbreviations used for cardiac parameters 
are: LV diameter during systole (LVDs) and diastole (LVDd), LV posterior wall during 
systole (LVPWs) and diastole (LVPWd), intraventrcular septal wall thickness during 
systole (LVSs) and diastole (LVSd), fractional shortening of the LV diameter (FS LVD), 




(n = 7-8) 
WT – TAC  
(n = 7-8) 
TgPer1R207Q  
Baseline 
(n = 2) 
TgPer1R207Q-
TAC (n = 2) 
Mass (g) 26.45 ±6 0.81 32.65 ± 1.15 32.75 ± 0.55 40.45 ± 2.8 
Heart rate 
(bpm) 366 ± 11.88 414.4 ± 26.32 413 ± 55 369.5 ± 65.5 
LVDs (mm) 2.65 ± 0.17 3.32 ± 0.10 3.12 ± 0.40 3.56 ± 0.24 
LVDd (mm) 3.78 ± 0.11 4.11 ± 0.11 4.57 ± 0.43 4.72 ± 0.14 
LVPWs (mm) 1.00 ± 0.06 1.15 ± 0.11 1.13 ± 0.15 1.18 ± 0.12 
LVPWd (mm) 0.67 ± 0.03 0.80 ± 0.04 0.74 ± 0.03 0.80 ± 0.11 
IVSs (mm) 0.96 ± 0.06 1.01 ± 0.02 1.12 ± 0.06 0.99 ± 0.15 
IVSd (mm) 0.64 ± 0.04 0.76 ± 0.03 0.84 ± 0.05 0.66 ± 0.23 
Aortic 
diameter (mm) 1.44 ± 0.02 1.75 ± 0.05 1.7 ± 0.02 1.77 ± 0.02 
Emax (mm/s) 590.2 ± 45.3 536.1 ± 37.62 551.3 ± 72.3 632 ± 28.1 
Amax (mm/s) 312.5 ± 25.05 356.9 ± 49.6 387.3 ± 49.65 376.6 ± 37.7 
E/A 1.90 ± 0.09 1.7 ± 0.20 1.425 ± 0.00 1.68 ± 0.09 
FS LVD (%) 30.18 ± 2.82 19.13 ± 0.83 32.08 ± 2.32 24.67 ± 2.89 
LVEF (%) 57.46 ± 4.42 39.78 ±1.51 60.25 ± 3.65 48.8 ± 4.80 
LV mass (g) 0.96 ± 0.01 1.03 ± 0.01 1.04 ± 0.00 1.005 ± 0.09 
Normalized 
LV Mass 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.02 ± 0.00 
SV (µL) 34.6 ± 2.34 29.88 ± 2.06 57.9 ± 9.38 50.28 ± 1.42 
Normalized 
Cardiac 






















Figure 32: G-V relationships of BKZero and BKSRKR currents   
Macroscopic BK currents were recorded from human (closed symbols) and mouse (open 
symbols) BKZero and BKSRKR channels at 0 (triangle), 1 (diamond), 10 (square) and 100 
(circle) µM Ca2+.  V1/2 values and number of patches used per variant for analysis are 










Figure 33: Currents recorded from hBK channel variants 
Representative macroscopic BK current traces recorded at the indicated Ca2+ 
concentration from inside-out patches from hBKZero, hBKSRKR, and hBKSRKR R640Q/R645Q 
channels.  Currents were recorded from separate patches.  Based upon previous 
experiments in our lab, we hypothesized that R640Q/R645Q would disrupt 
phosphorylation of S642, therefore eliminating the shift in G-V relationship between 









Figure 34: G-V relationships of hBKZero, hBKSRKR, and hBKSRKR R640Q/R645Q currents 
Based upon previous experiments in our lab, we hypothesized that R640Q/R645Q would 
disrupt phosphorylation of S642, therefore eliminating the shift in G-V relationship 
between hBKZero and hBKSRKR. Currents were recorded from hBKZero (open symbols), 
hBKSRKR (black symbols), and hBKSRKR R640Q/R645Q channels at 0 (triangle), 1 (diamond), 
10 (square) and 100 (circle) µM Ca2+.  V1/2 values and number of patches used per variant 
































Figure 35: Activation and deactivation kinetics for hBKR640Q/R645Q currents  
Activation kinetics were determined by fitting the rising phase of hBKZero (open symbol), 
hBKSRKR (black symbols), and hBKSRKR R640Q/R645Q (red symbols) currents to single 










100 µM 10 µM 1 µM 0 µM 
mBKZero -7 ± 2 (10) 46 ± 2 (10) 132 ± 3 (10) 186 ± 5 (9) 
mBKSRKR -4 ± 1 (10) 
79 ± 5 (9) * 
P < 0.0001 
181 ± 4 (18) * 
P < 0.0001 
211 ± 7 (8) 
hBKZero -14 ± 1 (14) 44 ± 2 (20) 154 ± 4 (8) 180 ± 6 (10) 
hBKSRKR -5 ± 3 (10) 
73 ± 3 (19) * 
P < 0.0001 
174 ± 3 (10) * 
P < 0.05 
225 ± 11 (8) * 
P < 0.001 
hBKSRKR 
R640Q/R645Q 
7 ± 3 (10) * 
P < 0.0001 
67 ± 2 (10) * 
P < 0.0001 
177 ± 6 (7) * 
P < 0.05 
212 ± 3 (11) * 
P < 0.01 
 
Table 9: V1/2 values for BKZero and BKSRKR currents 
Number of patches used to acquire data at each Ca2+ concentration is denoted in 
parenthesis.  Significance (*, P < 0.05) was tested using an unpaired t-test within mouse 
constructs, and a one-way ANOVA with Bonferroni post-hoc tests within human 
constructs at each Ca2+ concentration.  Comparisons were made against either mouse or 







Figure 36: Na+ inhibition of BK currents   
(A) Baseline macroscopic BK currents were recorded in an inside-out patch configuration 
from hBKSRKR channels in symmetrical K+ solutions at 100 µM Ca2+.  Solution was pH’d 
to 7.2 using NaOH.  Note the voltage-dependent inhibition of the current.  (B) Upon 
perfusion of symmetrical K+ solution pH’d with KOH, voltage-dependent inhibition was 
allieveated.  (C) Upon re-perfusion of solutions pH’d with NaOH, voltage-dependent 
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